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Abstract 
Rational drug design is underpinned by structural biology, in particular X-ray 
crystallography. This work aimed to explore a simple question; can electron 
microscopy (EM) play a useful role in the drug discovery process? To this end, 
two biological systems, the V-ATPase and Imidazoleglycerol-phosphate 
dehydratase (IGPD), were studied via EM. 
 
A modest (~1 nm) structure of the V-ATPase was solved via cryo-EM, 
permitting existing high resolution crystal structures to be accurately fitted in 
the context of the whole 1 MDa complex. This allowed new mechanistic insights 
to be uncovered. The dissociated V1 domain was studied to see if the 
mechanism of ATP silencing, used as a regulatory control, could provide new 
inhibitor targets to be identified. Although the specific mechanism could not be 
identified the resulting structures have shown a much more complicated 
regulatory mechanism than previously thought. The ubiquitous nature of the 
V-ATPase makes selectivity a significant challenge. To address this the binding 
mode of the selective V-ATPase inhibitor, Pea Albumin 1 subunit b (PA1b), was 
studied at low resolution using negative stain EM. Combined with biochemical 
analysis this has successfully identified the subunits responsible for binding 
PA1b. Furthermore, IGPD was used as a model system for high resolution 
cryo-EM studies to directly visualise inhibitor binding. A 3.1 Å reconstruction 
was obtained which allowed the de novo building of the atomic model and the 
identification of a small molecule inhibitor within the EM map. 
  
VII 
 
This work shows the potential of EM to provide valuable information for drug 
design at a wide range of resolutions, from rapid low resolution binding studies 
to direct visualisation of inhibitors at ~3 Å. 
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1. Introduction 
 
“Almost all aspects of life are engineered at the molecular level, and without 
understanding molecules we can only have a very sketchy understanding of life itself.” 
Francis Crick - What Mad Pursuit: A Personal View of Scientific Discovery 
(1988) 
 
“Does structure determine function, or does function determine structure, or does each 
determine the other, and if the latter, how can it be?” 
E. Stanley Abbot - The Causal Relations between Structure and Function in 
Biology (1916) 
 
1.1 Introduction to Structural Biology and Electron Microscopy 
It has long been acknowledged that the understanding of structure is crucial to 
our understanding of biology. In the 1920’s the field of structural biology as we 
know and understand it was born, with the work of Astbury and Bernal on 
X-ray fibre diffraction. A further milestone occurred in 1958, when building 
upon the pioneering X-ray studies of the Braggs in 1913 on crystalline salts, 
Kendrew showed the three dimensional structure of a protein for the first time 
(Kendrew et al., 1958), using myoglobin as his example. This was rapidly 
followed in 1960 by Perutz’s crystal structure of haemoglobin (Perutz et al., 
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1960). Following these first protein crystal structures, structural biology has 
gone from strength to strength. Now detailed structural understanding 
underpins many advances in biological understanding and informs the design 
of new therapeutic agents. In the years that followed Perutz’s and Kendrew’s 
landmark work, X-ray crystallography has remained the most widely used 
technique for the study of protein structure; indeed the protein databank (PDB) 
contains more than 100000 protein X-ray crystal structures along with an 
additional ~10000 structures from other techniques including NMR. 
 
An alternate technique for studying protein structure is electron microscopy 
(EM). Rather than studying the diffraction patterns formed from a highly 
ordered crystal lattice, EM is typically used to image individual particles of the 
specimen, removing the often difficult requirement for a well behaved crystal. 
While traditional light microscopy is limited to resolutions of ~200 nm by the 
wavelength of visible light, the wavelength of an electron accelerated to 100 kV 
is in the picometer range, allowing theoretical resolutions of smaller than an 
atom. The biological applications of EM were first explored in the 1960’s and 
70’s with several papers showing stained biological specimens and crystalline 
proteins (Brenner and Horne, 1959; De Rosier and Klug, 1968; Unwin and 
Henderson, 1975). However, it was not until the work of Dubochet in the 1980’s 
that EM began to show its true potential for structural studies of individual 
proteins. Dubochet’s innovation was to image the protein in a thin layer of 
vitreous ice, rather than dried and embedded in a heavy metal stain (Adrian et 
al., 1984; Dobro et al., 2010; Dubochet et al., 1988; McDowall et al., 1983). This 
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allowed finer details to be observed and avoided the harsh conditions 
previously required, which could introduce significant artefacts into the 
structure of the protein. From this point onwards improvements in technology 
have taken EM from producing low resolution envelopes or ‘blobology’ to 
obtaining near atomic resolution for a variety of biological macromolecules 
from molecular machines to viruses (Smith and Rubinstein, 2014). 
1.2 Potential for structure based inhibitor design by EM 
While, due to resolution restraints, the idea of EM as a tool for direct 
visualisation of inhibitor binding would have been far-fetched at best at the 
start of the project, a wealth of useful information is still available at the more 
modest resolutions (~5-10 Å) previously achievable. Given the developments in 
EM, leading to side chain assignment becoming achievable, what role could it 
play in the process of therapeutic discovery, in particular informing structure 
based inhibitor design? 
  
1.2.1 Current approaches to drug discovery 
The world is in constant need of new therapeutics, from the ongoing war 
against bacterial resistance to new therapies for diseases ranging from cancer to 
psychological conditions. However, the process of drug discovery is extremely 
slow and fraught with many hurdles and difficulties. One common approach to 
drug discovery consists of target-based drug design where a molecular target, 
for example an enzyme, is identified and modulated to hopefully produce the 
desired physiological effect. This can be achieved through screening techniques, 
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including natural product libraries, fragment libraries and high throughput 
screening (HTS) (Erlanson et al., 2016). In HTS an extremely large library of 
compounds is screened against a biological target of interest and any hits are 
then taken forward through development. Alternately rational drug design can 
be used, where knowledge of the structure of the molecular target is used to 
design new molecules which are hoped to exhibit binding/inhibitory properties 
(Lounnas et al., 2013). An  alternative to target-based drug discovery is 
phenotypic screening, where instead of aiming at a molecular target a 
phenotypic response is looked for in a model system of the disease (Moffat et 
al., 2014).  
 
While HTS has proved to be valuable in several different inhibitor development 
programs it does have drawbacks (Macarron et al., 2011). Firstly in order to 
perform a high throughput screen a large and drug like chemical library 
(~100,000-1,000,000’s) is needed, and while many large pharmaceutical 
companies possess in-house libraries ranging into the millions of compounds, 
this can be a hurdle for smaller companies or academic researchers. Indeed the 
costs associated with obtaining, curating and maintaining a compound library 
makes this process extremely difficult for many organisations. Secondly, within 
these large libraries only a small fraction of chemical space is covered, which 
may hinder discovery of inhibitors for targets with unusual binding sites. 
Furthermore, HTS is dependent on the ability to assay the target protein(s) in a 
high throughput manner while carefully tuning the assay conditions to ensure 
the best compound classes are identified as rapidly as possible. Additionally, 
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most HTS campaigns will focus on identifying a molecule which either binds or 
inhibits the molecular target, but inhibition of a single protein does not 
necessarily lead to a phenotypic effect.  
 
While phenotypic screening has the advantage that no molecular target needs 
to be identified in order to find a therapeutic possessing the desired effect, it is 
less commonly used relative to other methods. This is because it relies on 
possessing an extremely good model for the disease in question which can then 
be interrogated in a similar manner to HTS. However, only a small number of 
diseases have well researched, valid models and often the use of these is 
prohibitively expensive compared to an isolated enzyme for example. A further 
limitation is the difficulty in identifying the ‘targets’ which are being modulated 
by any molecules discovered in this way. While this knowledge is not required 
for a inhibitor to become a successful therapeutic, the lack of known target can 
hinder further optimisation efforts (Dominguez et al., 2014). 
 
1.2.2 Rational Drug Design 
In theory rational drug design overcomes some of the issues encountered by 
other approaches as a large compound library is not needed, nor is a detailed, 
expensive model system. By using prior knowledge of the target protein, small 
molecules can be designed which theoretically maximise binding potential 
(Clark, 2006). Although it must be noted that this assumes a much greater 
understanding of what happens upon ligand binding, and our ability to 
translate this to chemistry, than is perhaps true (Davis and Teague, 1999; Davis 
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et al., 2008). Traditionally rational drug design has been underpinned by 
structural information primarily obtained from X-ray crystallography and NMR 
studies. While X-ray crystallography has provided a wealth of structural 
information which has been used in rational design pipelines it does suffer from 
several limitations, including difficulty in obtaining crystals of the protein of 
interest (Niedzialkowska et al., 2016), crystal packing artefacts in the structure 
(Davis et al., 2008; Steuber et al., 2006; Søndergaard et al., 2009), issues with 
ligand geometry (Kleywegt et al., 2003; Liebeschuetz et al., 2012; Reynolds, 
2014), difficulties with low occupancy inhibitors, and showing only a static 
snapshot of the protein/inhibitor complex with restrictions in conformational 
changes that can be observed.  
 
The requirement for high resolution structures is a major bottleneck in rational 
drug design. For example, despite the PDB containing over 100,000 X-ray 
crystal structures, only 2821 are membrane proteins, clearly illustrating the 
difficulty in expression, purification and obtaining crystals of this important 
class of proteins which make up to 60% of drug targets (Overington et al., 2006). 
Although great efforts have been made to improve this, with some success in 
the use of crystallization techniques such as lipidic cubic phase it still proves a 
major challenge to reliably crystallize most membrane proteins (Caffrey, 2015). 
This lack of structural information in turn then prevents rational drug design 
being performed on the vast majority of membrane proteins and thus hinders 
the development of potential therapeutics. This is not just the case for 
membrane proteins; other potential drug targets such as viruses and rotary 
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motors have proven difficult to crystallize for a variety of reasons including 
flexibility and size. When a structure is obtained from crystallography there is 
also the possibility that some of the observed interactions are artificial and are a 
result of crystal packing artefacts. Crucially, a major drawback in using crystal 
structures for rational drug design is the rigid and static nature of the structure 
obtained (Teague, 2003). While inhibitor-bound crystal structures give the 
impression of a solid static protein binding to an equally static inhibitor the 
truth is that both are constantly moving and the protein behaves more like a 
firm gel than a rigid solid. As crystallography relies on each copy of the protein 
being identical in order to diffract in the lattice and only the most 
rigid/thermodynamically stable states of a protein typically crystallize, so any 
dynamic movements are lost.  
 
1.2.3 Advantages of EM 
Electron microscopy overcomes many of the hurdles and limitations 
experienced by crystallography. Instead of requiring large amounts of protein 
(mg scale) and a large amount of luck to crystallize one’s protein, EM only 
requires small amounts (µg scale) and no need for crystals (other than for 2D 
crystallography). This widens the number of targets that can be studied, from 
large macromolecules such as viruses to membrane proteins where the presence 
of detergent makes crystallization a challenge. EM also offers potential 
advantages for drug discovery by being able to trap different conformational 
states of a protein, moving away from static crystal structures to a dynamic 
ensemble of different states (Dashti et al., 2014; Frank and Ourmazd, 2016). This 
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could prove to be extremely powerful as inhibitor binding pockets can breathe 
and change as the protein samples different conformations. Additionally, while 
it may be possible to artificially trap a protein in other states in a crystal 
through the use of additives, it would be impossible to just add natural 
substrate and capture the protein in all stages of what may be a continuous 
process. EM has also been used to study proteins in more native conditions; for 
example TRPV1 with several bound ligands has been studied in the presence of 
native lipid through the use of nanodisks (Gao et al., 2016). Indeed the native 
lipid is thought to be crucial to the mechanism and to inhibition. 
 
However, in the past EM has not been a viable technique for structure-based 
drug design, primarily due to the low resolutions that had previously been 
obtainable, leading to EM being known as ‘blobology’. While in the past EM has 
been limited to around nanometer resolution at best for most samples, recent 
technological advances have now enabled near atomic resolutions (~3 Å) to be 
obtainable (Figure 1.1). Improvements in microscope stability and particularly 
the development of direct electron detectors (DED) have formed the basis for 
the renaissance of EM as a mainstream structural technique (Glaeser, 2016; 
Nogales, 2016; Smith and Rubinstein, 2014).  
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Figure 1.1 – Comparison of IP3R EM structures pre/post DED’s. (A/B) Cryo 
micrograph of IP3R on DED (A) and CCD (B). (C/D) Projections and class 
averages on DED (C) and CCD (D). (E/F) 3D reconstructions on DED (E) 
and CCD (F). Images adapted from (Fan et al., 2015) and (Jiang et al., 
2002). 
 
Direct electron detectors (DEDs) have not only increased the sensitivity and 
contrast of the images but also allow capture of high frame rate movies. These 
movies, in conjunction with new processing algorithms allow the motion of the 
specimen during the exposure due to both mechanical and beam induced 
movements to be partially accounted for, reducing the blurring of the image 
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and allowing higher resolution information to be recovered (Campbell et al., 
2012; Li et al., 2013a).  At the same time it also mitigates, to some extent, one of 
the largest remaining challenges in EM, radiation damage.  With these 
improvements allowing higher resolution structures to be obtained there have 
already been a number of structures published in complex with ligands and 
inhibitors, from large soluble complexes like the proteasome and 
β-galactosidase to smaller membrane proteins including the TRP channels and 
γ-secretase (Figure 1.2) (Bai et al., 2015b; Bartesaghi et al., 2015; da Fonseca and 
Morris, 2015; Gao et al., 2016; Li et al., 2016). 
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Figure 1.2 – Example EM reconstructions showing bound ligands. (A) 
β-galactosidase at 2.2 Å resolution showing bound PETG (Bartesaghi et al., 
2015)(EMDB 2984, PDB 5A1A). (B) Human p97 at 2.3 Å with bound 
UPCDC30245 inhibitor (Merk et al., 2016)(EMDB 3295, PDB 5FTJ). (C) 
TRPV1 at ~3 Å showing bound resiniferatoxin (Gao et al., 2016)(EMDB 
8117, PDB 5IRX). (D) Human proteasome at 3.6 Å with bound WLW-vs 
inhibitor (Li et al., 2016)(EMDB 3231, PDB 5FMG). 
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1.2.4 Limitations and developments in EM 
Although EM offers many exciting new possibilities to play a role in, and 
enhance, structure-based drug design, there are still several significant 
challenges that may hinder its widespread use. Foremost amongst these 
obstacles is the limited resolution which is currently obtainable. Despite recent 
advances (Merk et al., 2016), EM still lags behind X-ray crystallography in that 
obtaining ~1 Å resolution for biological specimens is not currently possible. 
This is a severe limitation as the exact details of binding mode and precise 
interactions between side chains and the ligand are only observable at these 
high resolutions. It is well established that EM can obtain atomic resolution 
structures in the materials field and is routinely used for this (Krivanek et al., 
2010; Spence, 1999; Urban, 2009). As such the main factors hindering obtaining 
high resolution in biological EM are twofold: the radiation damage sustained by 
the sample, and the movement of the specimen itself in the electron beam 
(Glaeser, 2016). 
 
While X-ray crystallography studies are also affected by radiation damage the 
problem is significantly worse for EM. Indeed it has been compared to a nuclear 
explosion at the specimen scale (Glaeser and Taylor, 1978; Orlova and Saibil, 
2011).  As direct detectors allow the capture of movie frames this allows the use 
of all the data including later frames from the exposure to be used to align the 
images giving higher contrast and easier alignment and then to use a subset of 
these frames with lower dose to perform the reconstructions, reducing some of 
the effects of radiation damage. However, it has been estimated that significant 
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loss of high resolution information occurs after doses of ~3 e-/Å2 (Baker et al., 
2010; Grant and Grigorieff, 2015), and much of this dose occurs within the first 
few frames of the exposure. Moreover, the frames that would contain this high 
resolution information suffer from the worst effects of beam induced motion, 
whereby as the grid is first exposed to the electron beam, large movements 
occur through poorly understood combinations of charging and 
expansion/contraction of the vitreous ice and the support film, typically made 
of amorphous carbon (Brilot et al., 2012; Glaeser et al., 2011). This means that 
with current methodology they cannot be used, making extremely high 
resolution (~ 1 Å) structures unlikely in the near future, although research into 
new support substrates is ongoing (Russo and Passmore, 2014; 2016; Yoshioka 
et al., 2010). Radiation damage can also have a more subtle effect aside from the 
degradation of resolution, where damage causes protein side chains to shift. 
Previous studies have shown that negative side chains appear to suffer more 
from radiation damage (Allegretti et al., 2014; Grant and Grigorieff, 2015), 
which is potentially due to decarboxylation of these side chains (Weik et al., 
2000), so if there are key negative residues in the binding pocket then this may 
induce a significant movement of the inhibitor or show a binding mode that is 
not physiologically relevant. 
 
EM can tackle proteins that are intractable for crystal studies such as large 
complexes and membrane proteins. However, current limitations in technology 
impose a size limit on the proteins that can be observed. Currently proteins 
smaller than ~250 kDa prove a major challenge for EM, though there are 
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exceptions to this, notably work carried by Subramanian and coworkers on 
isocitrate dehydrogenase and other small targets (Merk et al., 2016). While there 
are developments underway to improve this, and already significant progress 
through the use of direct detectors, this size limitation still hinders the use of 
EM for several important classes of drug targets including GPCRs. As such this 
is the subject of much ongoing research, particularly the development of phase 
plates. By inducing a quarter wave phase shift into the electron beam, the 
contrast close to – or at – focus, is greatly enhanced. While several designs of 
phase plate have been investigated in the past (Danev and Nagayama, 2001), 
the current technology is known as the Volta phase plate. Volta phase plates 
consist of a carbon film, heated to around 200 °C,  placed in the path of the 
beam, though how this induces phase shift is not yet fully understood (Danev 
and Baumeister, 2016; Danev et al., 2014). This technology has already allowed 
the structure of the human Prx3 (~250 kDa) to be obtained at 4.4 Å resolution 
(Khoshouei et al., 2016). Both phase plates and direct detectors are still in their 
infancy; with further development and optimisation this technology could 
enable EM to look at a much wider range of proteins than are currently viable. 
 
Another method in development to increase the range of viable proteins for 
study via EM is through the use of affinity grids (Yu et al., 2016). Structural 
study of several potentially therapeutically interesting proteins is precluded 
simply by difficulties in obtaining sufficient pure protein to carry out even EM 
studies, much less the orders of magnitude more required for crystal studies. 
This can be due to challenges in the overexpression including posttranslational 
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modifications, toxicity or mislocalisation. To combat this, rather than 
performing traditional purification and studying the resulting protein via EM, 
work is ongoing to purify the sample directly onto the EM grid. Various 
methods are being developed to achieve this, including immobilising antibodies 
to the grid surface to tether the protein of interest to the grid (Benjamin et al., 
2016) without any need for genetic modification. Alternatively Ni doped lipid 
monolayers can be applied to the grid surface to extract a His tagged protein 
directly. While currently the only examples of this work at high resolution have 
been highly symmetrical virus structures (Yu et al., 2016), with further 
development it could become a powerful technique for the structural study of 
hard-to-obtain proteins. 
 
A further drawback of EM for drug design purposes is the speed at which 
structures can be obtained. While with crystallography it is routine to set up 
several co-crystallizations or soaks simultaneously and the data collection for 
each crystal obtained is very rapid (minutes) (Blundell et al., 2002; O’Reilly et 
al., 2007), EM data collection is still relatively slow (Thompson et al., 2016), 
typically taking several days of microscope time for a single sample. While 
automated data collection has improved the situation (Carragher et al., 2000; 
Suloway et al., 2005; Tan et al., 2016), by increasing throughput from hundreds 
of micrographs collected manually a day to thousands, this is still a slow 
procedure compared to data collection on a crystal at a beamline.  
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For structure based drug design this is a particular issue, as a large number of 
analogue structures will typically be needed to build the structure activity 
relationship required for structure based drug design (Blundell et al., 2002). 
Nonetheless, new technologies in the field have the potential to partially 
mitigate this. For example, work is ongoing to improve the reproducibility of 
grid preparation, reducing the time spent optimising freezing conditions, 
thereby reducing microscope time for screening. One example of this is 
Spotiton, an automated grid preparation system, which rather than relying on 
using a relatively large (µl) droplet of sample and blotting most away, instead 
sprays a small (nl) volume onto a small section of the grid (Jain et al., 2012; 
Razinkov et al., 2016). Then this small volume is rapidly wicked away to a thin 
film, with tuneable thickness. This was made possible by the development of 
new grid designs, containing copper nanowires, which wick the liquid from the 
holes. As the sample only occupies a small portion of the grid ‘real estate’ it is 
easy to envisage applying multiple samples, for example a protein mixed with 
various inhibitors, onto different areas of the same grid. Although the data 
collection for each sample will remain slow, this would allow multiple data 
collections to occur without need for repeatedly changing grids and setting up 
automated data collection separately for each. 
 
Data processing is also typically significantly slower than crystallography, 
taking between weeks to months in order to extract the most from the raw data, 
possibly precluding EM as a high throughput structural technique. Tied to this 
is the volume of data produced in a single EM experiment, with a single 
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micrograph being between 1-10 GB in size, leading to datasets of 10+ TB for a 
single specimen. This presents a major infrastructure challenge and without 
significant resources dedicated to processing and data storage, makes the initial 
barrier to entry for EM substantial (Cianfrocco and Leschziner, 2015; 
Patwardhan et al., 2012; Thompson et al., 2016). Nevertheless, improvements 
are being made in speed of data acquisition and enhancing the speed of image 
processing. Computational power is constantly increasing, meaning the 
bottlenecks that currently hinder rapid processing of EM data should reduce 
over time. At the same time graphical acceleration of the processing pipeline 
using GPU technology is an active area of research with several key steps 
already optimised in this manner (Zhang, 2016), cutting processing times for 
these steps from days to hours. Further work is ongoing in utilising this 
dramatic acceleration to speed up the currently slow steps of classification and 
refinement. With the rapid rate of change in computational power and 
developments such as GPU acceleration, it is easy to envisage a processing 
pipeline for EM where several processing steps are carried out ‘on the fly’ as 
data is collected in an analogous manner to X-ray data collection (Lander et al., 
2009). 
 
Advances in technology and computation may also allow the use of EM to 
study biological processes in a time-dependent manner, giving insight into the 
dynamic changes that occur within the system. Work is ongoing to develop 
time-resolved EM through a variety of methods, including rapid 
mixing/spraying in order to physically trap the protein of interest in a variety 
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of functional states (Chen and Frank, 2016; Chen et al., 2015; Lu et al., 2009; M 
Walker, 1995), as well as computational manifold mapping approaches which 
have already been utilised to identify several functional conformational states 
of the ribosome (Dashti et al., 2014; Frank and Ourmazd, 2016). 
 
1.3 Membrane protein structure via EM 
It is estimated that 60% of drug targets are membrane proteins, including 
GPCRs, ABC transporters, ion channels and rotary ATPases, across a wide 
range of therapeutic areas from antibiotics to cancer (Overington et al., 2006). 
However, only ~3% of protein structures in the PDB are membrane proteins. 
This paucity of structural information hinders rational drug design efforts and 
slows the understanding of these vital systems. 
 
Until recently, high resolution structural information on membrane proteins has 
been obtained primarily from X-ray crystallographic data. However, the 
requirement for highly ordered crystals has made many membrane proteins 
and protein complexes intractable to crystallographic approaches. Until the 
recent developments in the field of cryo-EM, high resolution membrane protein 
structures via EM were only obtainable through electron diffraction of 2D 
crystals, with the highest resolution single particle EM structure pre-2009 being 
the RyR1 calcium-release channel at a modest 9.6 Å resolution (Ludtke et al., 
2005). This was not only a feature of the EM hardware but also the relatively 
small size of many membrane proteins of interest and their propensity to 
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aggregate, which precluded many high resolution structures from being 
obtained. Thus, historically only very large membrane proteins such as the 
rotary ATPase family were routinely studied via EM as their size and flexibility 
meant crystallographic studies were very demanding (Ludtke et al., 2005; 
Muench et al., 2011). 
 
With the modern developments in detectors and microscopes, the use of EM for 
the study of membrane proteins has been rapidly increasing.  Since the 
widespread adoption of direct detectors, several membrane proteins have had 
high resolution structures solved by EM including TRPV1, γ-secretase, RyR1, 
Cav1.1, NPC1 and Piezo (Figure 1.3) (Bai et al., 2015c; Gao et al., 2016; Ge et al., 
2015; Gong et al., 2016; Wu et al., 2015; Yan et al., 2015). Indeed the quality of 
the EM maps is now sufficient in some cases to permit the identification of a 
bound ligand or inhibitor as with TRPA1, TRPV1 and γ-secretase (Bai et al., 
2015b; Paulsen et al., 2015), perhaps opening the way for rational drug design 
informed via EM structures, an area previously reserved for crystallographic or 
NMR studies. 
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Figure 1.3 - Examples of sub nm membrane protein structures determined by 
cryo-EM. Examples showing EM reconstructions (grey density) of RyR1 
(EMDB-2807), Piezo1 (EMDB-6343), γ–secretase (EMDB-3061) and Cav1.1 
(EMDB-6475) with fitted atomic models. Figure adapted from (Rawson et 
al., 2016a). 
 
In 2006 there were 8 membrane protein structures deposited in the EMDB with 
an average resolution of ~22 Å (Figure 1.4). In contrast, in 2015 the number of 
deposited structures increased to 52 and the average resolution of these has 
improved to 12 Å (Figure 1.4). While not all published membrane proteins have 
been deposited within the EMDB, this does provide an approximate 
representation of a general trend. At the same time the average molecular 
weight of the membrane proteins released has remained relatively unchanged, 
perhaps surprising given the technological advances, particularly the use of 
direct electron detectors.  If the current trend in resolution was to continue, it is 
tempting to speculate that EM could become the structural technique of choice 
for membrane proteins in the future. However, it is worth noting that between 
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2013-2016 the highest resolution structure deposited has remained fairly stable, 
suggesting a plateau in resolution for membrane proteins at ~3.5 Å. 
 
Figure 1.4 - Mean resolution vs year of deposition within the EMDB. Analysis 
of the average resolution of deposited membrane protein structures within 
the EMDB in each year is shown in black. Highest resolution 
reconstruction deposited each year is show in grey. The general trend 
shows the resolution steadily increasing over time. Figure taken from 
(Rawson et al., 2016a). 
 
While advances in hardware and software within EM have enabled it to become 
a viable and valuable technique for structural studies of membrane proteins 
several challenges still remain. There will always be some of the same struggles 
faced by crystallography in obtaining and purifying sufficient amounts of 
protein and ensuring the protein's stability, although progress is being made in 
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the biochemistry to aid this (Abdul-Hussein et al., 2013; Bill et al., 2011; 
Frauenfeld et al., 2016; Tate, 2010). A further complication is the need to 
solubilise the protein in detergent; several EM studies have already shown that 
the choice of detergent plays a large role in the final resolution obtainable and 
indeed on whether the project is viable at all (Gao et al., 2016; Hauer et al., 2015; 
Lu et al., 2014). Indeed the function of several proteins is known to undergo 
large changes upon purification within a detergent (Postis et al., 2015), and 
other studies have shown the vital role played by phospholipids in stability, 
mechanism and inhibitor binding (Gao et al., 2016). This casts some doubt on 
the physiological relevance of many of the membrane protein structures 
currently available from both EM and crystal studies.  
 
While great progress has been made in producing and finding milder and more 
relevant detergents, they are still significantly different from the native 
membrane environment. Several groups have been developing methodology to 
combat this issue; of particular interest are the efforts to introduce a more native 
environment through the use of styrene maleic acid lipid particles (SMALPs) 
(Jamshad et al., 2011; Lee et al., 2016; Postis et al., 2015) and the progress being 
made in imaging proteins in situ, within a vesicle (Wang and Sigworth, 2009; 
2010). These in situ studies would not only allow protein activity to be 
measured in the imaged sample, but also potentially allow different 
conformations of the protein to be observed by inducing a membrane potential 
or a chemical gradient through the addition of additives to the sample. While 
this is an active area of research, it is likely that there will be no ‘one size fits all’ 
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general solution, and that the method of solubilisation will have to be optimised 
for each membrane protein in turn (Dörr et al., 2016; Kleinschmidt and Popot, 
2014). 
 
1.4 V-ATPase Introduction 
A group of particularly interesting membrane proteins for therapeutic design is 
the rotary ATPase family, which are membrane bound molecular motors that 
act either by hydrolysing ATP to drive a proton gradient or utilise an existing 
proton gradient to carry out ATP synthesis. They consist of the ATP synthase 
(F-ATPase), vacuolar ATPase (V-ATPase) and archaeal ATPase (A-ATPase) 
(Figure 1.5). An inhibitor targeting the F-ATPase (Bedaquiline) has already been 
approved as a treatment for tuberculosis, the first new approved treatment for 
this disease in 40 years (Mahajan, 2013). The V-ATPase plays an essential role in 
several physiological processes (Marshansky et al., 2014), and therefore is found 
in all eukaryotic cells (Forgac, 2007).  It is thus unsurprising that the complex is 
implicated in a variety of disease states (Hinton et al., 2009). For example its 
role in bone resorption means that it is involved in osteopetrosis (Blair et al., 
1989). The V-ATPase has also been linked to cancer invasiveness and has been 
studied as a target for cancer therapies (Fais et al., 2007; Perez-Sayans et al., 
2009; Sennoune et al., 2004). However, there are currently no therapeutically 
viable inhibitors targeting the V-ATPase and little previous effort has focussed 
on a rational design-led approach as complete structural information has 
proved extremely challenging to obtain. 
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Figure 1.5 – Schematic representations of the rotary ATPase family. V,A and 
F-ATPase schematics shown from deposited atomic models with subunits 
labelled (Rawson et al., 2016b). 
 
The common feature of the rotary ATPase family is the coupling of a membrane 
bound proton translocating domain and a soluble, ATP 
hydrolysing/synthesising motor. While each member of the family has a high 
degree of similarity with the others, they posses varying degrees of complexity 
(Muench et al., 2011). The best studied system; the F-ATPase (often referred to 
as the ATP synthase) (Walker, 2013), is the simplest of the family, possessing 
only one stator. It primarily uses the proton gradient and flow of H+ through 
the Fo domain to generate torque and drive ATP synthesis in the F1 region. ATP 
synthesis is carried out through the Boyer mechanism (Boyer, 1997) (Figure 1.6). 
This consists of a cycle where the three AB pairs move through open, loose and 
tightly bound states as ADP and phosphate is bound, ATP is formed and finally 
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released. Functional and structural studies have identified several additional 
sub-states within the catalytic cycle (Masaike et al., 2008; Yasuda et al., 2001), 
with EM studies on the yeast complex finding 7 separate sub-states (Zhou et al., 
2015).  
 
Figure 1.6 – Diagram of the Boyer Mechanism. Schematic of the Boyer 
mechanism of ATP synthesis showing the cycling between loose (L), tight 
(T), and open (O) sites as ADP and Pi binds and ATP is released. 
 
Recent EM and crystallography studies have shown the interface where proton 
translocation occurs between the rotating c-ring and the static subunit a 
(Morales-Rios et al., 2015; Zhou et al., 2015). At this interface the proton enters 
one side of a half channel within a, is picked up by a conserved glutamate 
residue on the c-ring and following a full rotation of the rotor is then removed 
into the half channel on the opposite side (Figure 1.7).  
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Figure 1.7 - Illustration of proton translocation. Diagram showing proton 
translocation across a membrane with the protons entering via a half 
channel, are driven around the c-ring and exit via a second half channel. 
 
While generally shown as a monomer it has been shown that in many systems 
the F-ATPase exists as a dimer with each complex bridged by subunits e, g and 
k (Hahn et al., 2016). The F-ATPase has also been implicated in membrane 
remodelling and appears to induce ridges in membranes with the F-ATPase 
dimers lying in rows along the ridge (Figure 1.8) (Davies et al., 2012; Mühleip et 
al., 2016). Studies have shown that this V-shaped arrangement is crucial for the 
function of the complex and has been compared to the arrangement of pistons 
within an engine (Stewart et al., 2013). 
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Figure 1.8 – F-ATPase dimers. Example dimers of the F-ATPase from (A) 
Yarrowia lipolytica (EMDB-8151) and (B) Polytomella sp. (EMDB-2852) 
(Hahn et al., 2016). 
 
The second member of the ATPase family is the A-ATPase, which differs in 
organisation to the F-ATPase in having two stators rather than one (Lau and 
Rubinstein, 2012; Schep et al., 2016). Each of these stators is made of just two 
coiled coils rather than the multi-subunit stator found in the F-ATPase, similar 
to the V-ATPase.  It is found in archaeal bacteria and unlike the other two 
members of the family can both hydrolyse and synthesise ATP depending upon 
the requirements of the organism. Despite the differences in function and in 
structure, the A-ATPase is still often referred to as the V/A-ATPase within the 
literature. 
 
Of particular interest is the V-ATPase, which acts via the hydrolysis of ATP in 
order to drive proton translocation across a membrane.  The V-ATPase has the 
same overall architecture as the other ATPase family members consisting of the 
soluble ATP hydrolysing domain (V1) and the membrane bound proton-
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translocating domain (Vo).  V1 consists of three AB subunit repeats where ATP 
hydrolysis takes place, subunits D and F that make up the top of the rotating 
axle, and three stator stalks consisting of subunits E and G in a coiled coil. The 
three stators are linked by a series of ‘collar’ subunits, C, H and the soluble 
domain of subunit a. The membrane embedded Vo domain consists of the 
c-ring, made up of a variable number of c subunits and the remainder of 
subunit a. There can also be variations of the subunit composition of the c-ring 
with modified c’ and c’’ observed in some species. However, given the observed 
step size in the F-ATPase and the varying number of c subunits present in 
differing V-ATPases, this is calculated to result in a non integer number of 
protons crossing the membrane per ATP (Nakanishi-Matsui et al., 2010). In 
addition there is a symmetry mismatch between the two domains of the 
complex, with the V1 domain having three sites for hydrolysis in comparison to 
the variable stoichiometries of the c-ring in the Vo domain. These factors 
combine to create a mismatch in the energies required. It has been proposed 
that some form of energy storage mechanism within the complex is required 
(Nakanishi-Matsui et al., 2010), and it has been speculated that the stators may 
play this role, storing excess energy through torsion, and releasing when 
required. 
 
In some environments the V-ATPase is thought to consume up to 10% of 
cellular ATP, making regulation extremely important (Dow, 1984; Huss and 
Wieczorek, 2007). The complex therefore requires a mechanism to sense and 
respond to several factors including ATP and amino acid concentration (Cotter 
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et al., 2015; Stransky and Forgac, 2015). Previous work on the complex from 
both yeast and M. sexta has shown that under low levels of ATP induced by 
starvation the complex is regulated via some degree of dissociation between the 
V1 an Vo domains (Kane, 1995; Sumner et al., 1995). While the studies in yeast 
have suggested full dissociation of the domains, imaging studies of the M. sexta 
complex suggest that the localisation of the V1 domain does not move from the 
membrane region, suggesting a more complex mechanism than simple 
dissociation (Tabke et al., 2014).  
 
Following this dissociation the Vo domain becomes impermeable to protons, 
preventing leakage, and the V1 domain can no longer hydrolyse ATP, 
preventing futile ATP consumption. However, the structural changes 
associated with the silencing of ATP hydrolysis in the V1 domain are not yet 
fully understood. Several studies have suggested that this silencing is due to 
interaction between subunit H and the central rotor axle (Diab et al., 2009; 
Jefferies and Forgac, 2008). Indeed, crystal structures are now available which 
support this theory (Oot et al., 2016), although this conclusion may be due in 
part to artefacts introduced by crystal contacts, discussed in more detail in 
Chapter 4. Also, the resolution of the crystal structure is very low (6.2 Å, within 
the bottom ~0.1% of entries in the PDB), potentially leading to uncertainty in 
the phasing of the structure. Additionally, low resolution EM studies have not 
been able to identify any density which can be assigned to the H subunit in 
isolated V1 samples (Muench et al., 2014b).  
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During normal activity, a mechanism must also be in place to prevent futile 
rotation of the ATPase or backwards rotation of the c-ring which would 
drastically lower the efficiency of proton translocation. In order to achieve this 
some form of brake or ratchet-like mechanism would be required. Indeed some 
additional mechanism, not found in A-ATPases, must be present to prevent the 
V-ATPase from acting as an ATP synthase under low ATP conditions. 
 
In order to exploit the V-ATPase as therapeutic target, an additional level of 
complexity must be considered: the isoform specificity of the inhibitor. While 
many inhibitors for the V-ATPase already exist, including bafilomycin (Zhang 
et al., 1994), archazolid (Huss et al., 2005), and the enamide inhibitors (Huss and 
Wieczorek, 2009), they are extremely toxic and thus unsuitable as therapeutics 
due to their isoform promiscuity, with some exceptions (Niikura et al., 2004). 
For example, while it may be beneficial to inhibit the V-ATPase in osteoblasts in 
order to treat osteopetrosis, if other V-ATPase isoforms throughout the body 
are also inhibited the effect would likely be lethal. Due in part to a lack of 
detailed understanding of the mode of action of these inhibitors, and no high 
resolution structure of the intact complex, it has so far been challenging to 
design inhibitors which do not suffer from this drawback. 
 
It is interesting to note that subtle differences between the rotary ATPases of 
different families may allow selective targeting of some species. For example, 
while the F-ATPase appears to be vital for the survival of the malaria parasite 
during the mosquito phase (Sturm et al., 2015), no homologue for the crucial 
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subunit a required for proton translocation can be identified in BLAST searches 
(Balabaskaran Nina et al., 2011). This suggests that either subunit a is scavenged 
in some manner from the host organism or that it exhibits a drastically different 
sequence and fold than typical, so it cannot be found through BLAST searches, 
though some candidates for the a subunit have been proposed (Mogi and Kita, 
2009). This may allow for it to be targeted with a degree of specificity. Subunit a 
also cannot be located within the related Toxoplasma gondii and Neospora 
parasites (Seeber et al., 2008), potentially hinting at a common sequence within 
the larger Apicomplexa family. Substantial differences also exist across species 
going from prokaryotic systems to simple eukaryotes such as yeast and onto 
higher eukaryotes. These differences come in both structure and function and 
are relevant to the crucial questions of regulation within the complex. In 
addition to reported differences in dissociation between the yeast and the M. 
sexta complex, additional factors have been identified within the yeast system 
that are required for re-assembly of the complex, including RAVE (Smardon et 
al., 2002; Smardon and Kane, 2007), although re-assembly has not been directly 
observed and is still poorly understood. 
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Figure 1.9 – Improvement in EM reconstructions of the rotary ATPase. (A) 
F-ATPase structures determined by EM at ~32 Å, 18 Å and 6.4 Å 
resolution (EMDB accession codes: 1357,2091,3169). (B) A-ATPase 
structures determined by EM at ~16 Å, 9.7 Å and 6.4 Å resolution (EMDB 
accession codes: 1888,5335,8016). (C) V-ATPase structures determined by 
EM at ~17 Å, 11 Å and 6.9 Å resolution (EMDB accession codes: 
1590,5476,6284). Figure taken from (Rawson et al., 2016a). 
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In many respects structural studies of the rotary ATPase family have mirrored 
the progress within the wider EM field (Figure 1.9). This is due to the 
continuing evolution in EM, brought on by improvements in all areas of the 
technique; from the microscope stability, detector performance, to improved 
algorithms and crucially better sample preparation. These advances have 
allowed ever higher resolutions to be attained and in doing so have formed the 
basis for greater functional understanding of these vitally important molecular 
machines. When the work in this thesis was undertaken there were several 
unanswered questions and challenges relating to the V-ATPase including: a sub 
nm resolution structure of the intact complex, the structural identification of 
catalytic states within the complex, the architecture of the proton translocating a 
subunit, the location and purpose of subunit e, and the mechanism of regulation 
of the complex. This thesis aimed to address some of these issues. 
 
Furthermore, this thesis will explore the potential of EM to inform drug design, 
focussing initially on the V-ATPase. EM will be used to improve structural 
knowledge of the V-ATPase, leading to insights into mechanism, regulation and 
ultimately inhibition. Studies on a model system will focus on the power of 
high resolution EM structures, made possible by advances in technology, to 
inform inhibitor design. 
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2. Materials and methods 
2.1 Basic background/Instrumentation 
2.1.1 Image Formation 
All electron microscopes have the same broadly similar layout and components, 
consisting of an electron source, a series of magnetic lenses, a specimen holder 
and a detection system, all of which are held under vacuum (Figure 2.1). 
 
Figure 2.1 – Electron microscope schematic. Schematic drawing of an electron 
microscope showing beam path (grey) and lenses (blue). 
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In transmission electron microscopy (TEM) the image observed is a projection 
of the specimen made from electrons which have been transmitted through the 
sample and scattered (Orlova and Saibil, 2011). This scattering can occur in two 
ways; elastically scattered electrons, where the path of the electron is altered but 
no energy is transferred, and inelastic scattering, where energy is deposited 
from the incident electron to the sample. In standard TEM, while both types of 
scattered electrons are collected, only elastically scattered electrons are useful 
for image formation. However, it is estimated that for each elastic scattering 
event 3-4 inelastic events occur (Henderson, 1995). The energy deposited into 
the sample by these electrons can cause many detrimental effects including 
direct damage to the sample, formation of free radicals and bond 
rearrangement. These damaging effects are a key limitation in EM of biological 
specimens, due to the exposure times needed to form a usable image and the 
inability to recover the information from the earliest part of the exposure 
(Glaeser, 2016), which will be discussed in more detail elsewhere (Chapter 1). It 
is also possible for a single electron to undergo multiple scattering events as it 
passes through the sample layer, adding to the noise in the image. To minimise 
this it is thus important that the specimen layer is kept as thin as possible to 
lower the chances of multiple scattering events. 
 
A further complication in the imaging of biological samples via EM is contrast. 
Again contrast can be split into two categories; phase contrast and amplitude 
contrast. In materials with a high atomic number, for example commonly used 
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stains containing uranium, amplitude contrast dominates. This results from the 
loss of electrons due to high angle scattering by the heavy metal. However, for 
light atoms for example O,N,C,H that make up the majority of protein, there is 
very little absorption and thus amplitude contrast is minimal for an unstained 
protein. In this case phase contrast dominates, which results from interference 
between the scattered and unscattered beam. Unfortunately biological samples 
are also classified as weak phase objects, meaning that they induce not only 
minimal amplitude contrast, but also very little phase shift leading to little 
phase contrast (Orlova and Saibil, 2011). To counter this, the ideal optics of the 
microscope must be sacrificed through the use of defocus to generate a larger 
phase shift and thus a higher contrast image. The need to defocus further 
complicates the processing of the images and high defocus can limit the 
practically obtainable resolution. Thus data collection becomes a balance 
between achieving sufficient contrast through dose and defocus to see, pick and 
align particles and imaging close enough to focus and with as small a dose as 
possible to preserve as much high resolution information as possible. 
 
2.1.2 Detectors 
The method of recording the image is of vital importance to the quality of the 
data obtained and thus the potential resolution possible. There have been three 
widely used methods of recording images; film, charge-coupled device (CCD) 
cameras and direct electron detectors (Figure 2.2), each with distinct advantages 
and disadvantages. The oldest and simplest detection system is film where the 
image is formed through interaction of the scattered electron with a thin layer 
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of silver halide causing a chemical reaction/rearrangement of the surface 
material at the point of electron interaction. Until the advent of direct detectors, 
film was the recording medium of choice for high resolution studies (Bammes 
et al., 2011). Its fine grain size gave a high sampling while also giving a large 
field of view and a greater detector quantum efficiency (DQE) at high spatial 
frequencies than a typical CCD camera (McMullan et al., 2009a). However, film 
is expensive to buy, difficult to work with, limits the number of images that can 
be taken in a single session, and is slow to process, requiring first processing in 
a dark room and then digitising before use in EM processing packages.  
 
In comparison, CCD cameras are relatively cheap, easy, and quick to use. CCDs 
operate through the conversion of the incoming electrons to photons via a 
scintillator layer. The photons are then carried via fibre optic to a CCD chip, 
digitized into an electronic signal and read out. Due to this series of conversions 
a large amount of noise is introduced into the image and typically the DQE of a 
CCD camera is significantly lower than film, particularly at high resolutions.  
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Figure 2.2 – Detector Schematics. Schematic representation of a CCD camera 
(A) and a DED (B) 
 
Recent advances in detector technology have allowed the direct detection of 
electrons (Faruqi and McMullan, 2011; McMullan et al., 2014). Increases in the 
robustness of detectors, brought on through monolithic active pixel sensor 
(MAPS) technology (Faruqi et al., 2005), increased radiation hardness over 
traditional CCDs. Substantial thinning of the sensing layer minimises spreading 
of the signal, and backscattering events, which results in higher resolutions 
being obtainable (McMullan et al., 2009c). Another advantage of this method of 
detection is the high frame rate of the detectors, which allows images to be 
recorded as multiple frame movies rather than a single integrated image. This 
makes dose fractionation and drift correction possible by utilising the ‘movie 
frames’ which will be discussed in more detail in Section 2.4.1. Direct detectors 
currently act in one of two modes, integrating or counting, each with 
advantages and drawbacks. Integrating detectors such as the FEI Falcon II 
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combine the signal from all electrons hitting the detector, which due to 
variability in electron energy can add noise to the final output, but this mode 
allows short exposure times and higher dose rates. In comparison, counting 
mode detectors like the Gatan K2 count individual electrons as they hit the 
detector (McMullan et al., 2014; 2009b), which with robust counting algorithms 
can more accurately localise the position and path of each electron. Indeed 
some detectors have ‘super resolution’ capability where sub-pixel localisation 
allows information beyond the Nyquist limit to be obtained. However, counting 
and super resolution modes rely on extremely low dose rates to minimise the 
potential for multiple electrons hitting the same pixel at any given time (Li et 
al., 2013b), and this in turn leads to much longer exposure times, which slows 
data acquisition. Thus these modes may suffer more from any mechanical 
specimen drift. 
 
In order to image a biological specimen, it must be held on some form of 
support in the microscope. The grids that are generally used for EM studies 
consist of a metal mesh, generally copper, at a set spacing in a circular grid ~3 
mm in diameter. Depending on the nature of the individual experiment, a 
variety of different support films are then added ranging from a continuous 
layer of amorphous carbon or regular arrays of holes in a carbon film to more 
exotic materials such as gold or graphene films. The hole size chosen, as well as 
the material used, can have profound effects upon how the sample is 
distributed on the grid. The quality of the image can also be directly affected by 
the support chosen. For example, different amounts of beam induced motion 
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and drift have been observed between the standard carbon support film and 
so-called UltraFoil grids made from gold (Russo and Passmore, 2014). 
2.2 Negative stain EM 
Negative staining is used for low resolution EM studies of protein samples 
where the protein of interest is first coated in a thin layer of a heavy metal 
staining solution (Ohi et al., 2004). This heavy metal stain provides contrast in 
the microscope through amplitude contrast as described above. The sample is 
typically prepared on a grid with a continuous carbon support film which has 
been made hydrophilic by treatment either by irradiation under a UV lamp or 
exposure to a plasma in the form of plasma cleaning or glow discharge. A key 
advantage of negative stain analysis is the small amount of protein required, 
with typical protein concentrations in the nM range. The protein is first applied 
to the grid surface and allowed to adsorb onto the support film before blotting 
to remove excess liquid, washing if desired, and application of the staining 
solution (Booth et al., 2011). Depending on the precise method used, the stain is 
either blotted away and reapplied a number of times or flooded over the grid 
repeatedly. A variety of different heavy metal stains are available, including 
different uranyl and molybdenum salts, with the grain size of the staining 
solution limiting the maximum resolution obtainable. The most widely used 
stain, uranyl acetate, gives a maximum resolution of ~15 Å. In order to obtain 
good quality negative stain grids the particle distribution needs to be optimised 
by altering concentration. Crucially the stain depth must also be varied, which, 
depending on technique, can either be by varying staining time or number of 
applications of the stain. A key advantage of negative stain is the relative speed 
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and ease with which it can be performed, allowing the user to rapidly assess 
sample quality before performing more arduous cryo-EM studies. 
2.3 Cryo EM 
Cryo-EM studies involve imaging the specimen of interest in a thin film of 
vitreous solution maintained at cryo temperatures (< -180 °C) to prevent 
formation of crystalline ice which would damage the fragile protein and 
interfere with the imaging conditions. The preparation of cryo samples is more 
challenging than negative staining due to the constant temperature requirement 
and sensitivity to contamination during grid preparation and loading 
(Grassucci et al., 2007). Holey carbon films are typically used for cryo-EM rather 
than the continuous carbon coated grids used for negative stain, although the 
size and organisation of these holes can vary as can the support material. Before 
application of sample, the grid must first be treated with glow discharge or UV 
in the same way as a negative stain grid in order to make the surface 
hydrophilic, although the exact method of treatment and time will vary 
depending on the sample in question and the support film used. In order to 
obtain the vitreous film, the sample is suspended between holes on a support 
film by applying the sample and then blotting away excess so only a thin film 
remains. The grid is then plunged into a cryogen to rapidly vitrify the sample 
(Cabra and Samso, 2015; Grassucci et al., 2007; Orlova and Saibil, 2011)(Figure 
2.3).  
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The process of blotting and plunge freezing is usually carried out with 
specialised equipment, for example the FEI Vitribot. Depending on the 
equipment, the user can alter a number of parameters with the aim of 
optimising ice thickness on the grid.  This includes the number of blots, how 
long the sample is blotted for, and any wait time between blotting and the 
plunge into the cryogen. Typically, liquid ethane is used as a cryogen rather 
than nitrogen because this avoids the formation of an insulating vapour layer 
which would slow the cooling process and lead to crystalline ice formation, 
although ethane/propane mixtures can also be used. Following vitrification, the 
grid is transferred to a storage puc under liquid nitrogen until required for 
imaging. In order to be imaged the grid must be transferred into a specially 
designed sample holder and inserted into the microscope without warming 
above approximately -160°C, significantly complicating the procedure in 
comparison to negative stain (Grassucci et al., 2008). 
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Figure 2.3 – Cryo Grid preparation schematic. Workflow of cryo-grid 
preparation adapted from (Orlova and Saibil, 2011). Initially sample is 
applied to the grid, then blotted to a thin layer prior to plunge freezing 
into the cryogen. This captures particles in random orientations in the 
vitreous ice and the grid is transferred into a microscope for imaging. 
 
As biological specimens are extremely sensitive to radiation damage it is vital to 
control and limit the electron dose received by the sample (Baker et al., 2010; 
Grant and Grigorieff, 2015; Stark et al., 1996). In typical cryo data collection 
conditions this is achieved through a technique known as low dose imaging. 
For this reason microscopes are generally equipped with a low dose mode. In 
this technique the grid is first viewed in ‘search mode’ that uses low 
magnification and minimal dose to find the desired imaging area. Once an area 
has been selected, the beam is focused away from the area of interest, at a set 
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distance and angle so that the specimen is not pre-exposed, before imaging the 
desired area. 
  
Software developments and improved hardware integration have allowed data 
to be collected in a semi-automatic fashion. Rather than the user collecting each 
micrograph by hand then finding another imaging area and moving manually 
before focussing and imaging again, this can now be performed by software. 
Programs including Leginon (Carragher et al., 2000), SerialEM (Mastronarde, 
2005), and EPU are all able to provide some degree of automation. While 
different software packages exist, each with different levels of user interaction 
depending on budget and hardware manufacturer, the general principles are 
consistent for all. In most cases a series of low magnification images are taken of 
the grid to build up a mosaic overview. From this, the user selects areas of 
interest based on desired criteria, for example thin ice, no cracking, and low 
contamination. If a grid type with a regular array is used, then a template can 
be specified so that viable holes for imaging are detected automatically. After 
selection of the desired areas, the program proceeds to image each of these in 
turn, checking defocus and correcting at set intervals. This allows data 
collections to continue for long periods without user intervention, maximising 
the efficiency of the time available. As well as allowing longer data collection 
sessions and making data collection significantly easier, another advantage is 
that the software is sometimes able to image in ways challenging for humans, 
for example taking several images in each hole using beam deflectors to 
increase total data obtained. 
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2.4 Image processing 
Once the images have been collected, several processing steps are then required 
to go from noisy, low contrast micrographs to a high resolution structure. Each 
of these steps aims to either correct for imperfections in the imaging conditions 
or to deal with extracting the relevant data, aligning and averaging the images. 
While the exact order of these steps may vary slightly depending on the user’s 
preference or the nature of the data obtained, it is possible to simplify this into a 
rough schematic (Figure 2.4). Each of these steps will be described in more 
detail in the subsequent sections below. 
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Figure 2.4 - EM processing workflow. Workflow showing typical processing 
steps taken in a cryo-EM project. 
 
2.4.1 Movie correction 
Due to the high frame rates of the new generation of DEDs it is possible to 
obtain a series of frames or a ‘movie’ from a single exposure rather than the 
single sum of the whole exposure, which was obtained using older recording 
media including film and CCDs. By utilising the movie frames obtained from 
DEDs, both the movement of the sample and the damaging effects of the 
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electron beam can be mitigated to some extent. Large movements due to 
mechanical stage drift can be corrected for at the whole frame level, while more 
subtle and complex movements of the particles, which result from exposure to 
the electron beam, can be corrected for on a particle by particle basis. In 
addition to this motion correction, some of the effects of radiation damage can 
be lessened by the removal or weighting of later frames from the exposure, 
leaving only the frames containing the high resolution, undamaged information 
for reconstruction (Figure 2.5). This has allowed a new data collection strategy 
to be used, where very high (70-100 e-/Å2) doses can be used in order to 
generate higher contrast and improve picking and low resolution orientational 
assignments, before removal of the later, damaged frames, for use in high 
resolution reconstructions. 
 
To carry out dose weighting, programs can use a standard curve of radiation 
damage at different resolutions, either from studies carried out on 2D crystal 
diffraction patterns (Baker et al., 2010), or more recently, using observed 
damage in high resolution single particle reconstructions (Grant and Grigorieff, 
2015). This curve can then be directly used to weight each frame dependent on 
the dose received at that point. Alternatively, the data can be assessed on a 
case-by-case basis, for example particle polishing within RELION (Scheres, 
2014). This module calculates a ‘B-factor’ for each individual frame based upon 
the quality of a 3D reconstruction from each frame individually. As the precise 
extent of radiation damage is likely to be subtly different on a case-by-case 
basis, this method may be potentially more accurate. However, if the quality of 
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each frame reconstruction is not sufficient to accurately calculate a B-factor then 
the results may be unreliable. To combat this, frames can be averaged to 
improve the signal for estimation, but this comes at the expense of precision of 
the weighting obtained. 
 
 
Figure 2.5 - Motion correction overview. Overview of motion correction 
showing first alignment of frames followed by weighting/removal of 
damaged frames prior to averaging to final corrected micrograph. 
 
At the whole-frame level, there are several software packages available to carry 
out this motion correction including MOTIONCORR (Li et al., 2013a), 
alignframes_LMBFGS (Rubinstein and Brubaker, 2015), Unblur (Grant and 
Grigorieff, 2015), and modules within EMAN2 (Tang et al., 2007). While the 
details of each program differ slightly, the core principle is that each frame is 
compared to the other frames in the stack and then shifted to maximise the 
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correlation between the stack. Variations include using a single frame as a fixed 
point of reference or aligning each frame to the sum of all frames and iterating 
this process after each frame has been moved. Whole frame motion correction is 
typically the first operation performed on movie frames as by accounting for 
this motion the accuracy of all subsequent steps in processing is improved, 
especially for long exposure movies often obtained from K2 detectors. While 
this is a valuable method for removing large, generally unidirectional shifts, it 
fails to capture the complex motions of individual particles. 
 
In order to better capture the complex ‘swirling’ motions that particles within a 
micrograph undergo each particle must be considered both individually and 
correlated to its neighbouring particles (Figure 2.6). This can be carried out by a 
variety of software packages including the particle polishing module within 
RELION, alignparts_LMBFGS and Unblur.  
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Figure 2.6 - Particle motion example. Example of complex trajectories taken by 
single V-ATPase particles in ice following exposure to electron beam 
(Chapter 3).  Generated in alignparts_LMBFGS (Rubinstein and Brubaker, 
2015). 
 
2.4.2 CTF correction 
The need for contrast transfer function (CTF) correction is a direct result of the 
inability to create the perfect microscope. CTF can be thought of as the 
mathematical description of the microscope’s point spread function. It results 
from the combined effect of all the imperfections within the imaging conditions, 
including chromatic and spherical aberrations within the lens systems as well as 
any other flaws within the microscope. Thus images that are recorded can be 
thought of as a convolution between the information in the object imaged and 
the CTF of the microscope, with the addition of noise from imperfect detectors. 
As the effects of CTF occur in a periodic manner related to resolution, the 
resulting power spectrum is generally plotted in Fourier space as an oscillating 
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curve with decaying amplitudes at higher resolutions. As previously discussed, 
defocus is a necessary evil in cryo-EM; in order to generate contrast within 
weak phase biological specimens defocus must be introduced in the imaging 
process. However, increasing defocus leads to higher frequency oscillations and 
the shifting of the curve towards lower resolutions, acting to reduce the amount 
of high-resolution information recovered.  
 
The first step of CTF correction is the determination of the defocus and CTF 
parameters of the data. Several programs, including CTFFIND (Rohou and 
Grigorieff, 2015) and gCTF (Zhang, 2016), estimate the defocus of each 
micrograph and attempt to accurately model the power spectrum of the 
micrograph. This is then accounted for during subsequent CTF correction steps 
(Mindell and Grigorieff, 2003; Rohou and Grigorieff, 2015; Zhang, 2016).  It is 
also possible to calculate a defocus value for each particle within a micrograph, 
which can account for a defocus gradient across a micrograph and/or 
differences in each particle’s z position within the ice layer. 
 
The oscillating nature of the CTF leads to several spatial frequencies with zero 
contrast at any given defocus value and negative values at several points. Thus 
the simplest form of CTF correction is phase flipping to remove any negative 
values. The simplest method to remove the zero points is to vary the defocus 
value across a range of a few microns during data collection so that when the 
data are averaged together no zero points will remain. There are also more 
complex treatments including amplitude correction, which seek to account for 
  
52 
the decaying amplitudes at higher spatial frequencies. However this approach 
requires an extra layer of complexity due to the low SNR of EM images of 
biological specimens, which could lead to an amplification of noise rather than 
signal unless the data are optimally filtered. This complex treatment is 
automatically carried out within several software packages including XMIPP 
and RELION (Scheres, 2012; Scheres et al., 2008). 
 
2.4.3 Particle Picking 
The first step of single particle processing is selecting the particles themselves. 
Particle picking can be manual, semi-automatic or fully automated. While 
manual picking, where the user selects each particle individually, allows 
greater control and confidence in the particles picked, it is extremely slow and 
laborious, particularly for low contrast cryo datasets often consisting of 1000s of 
micrographs. The throughput can be increased by using automated methods 
including swarm picking in EMAN2 (Tang et al., 2007), and automatic particle 
picking in RELION (Scheres, 2015), and Gautomatch (In development by Kai 
Zhang (Urnavicius et al., 2015)). These programs require the user to pick a 
number of particles which are classified and averaged to make templates used 
for automated particle selection. The programs then attempt to find any density 
in a micrograph that matches the templates provided, with additional user 
parameters to minimise the selection of contamination, aggregation or particles 
lying on the support film. However, the introduction of a template can 
potentially introduce bias into the data, particularly if a template is obtained 
from an existing structure or is not filtered to low resolution (Henderson, 2013; 
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van Heel, 2013). Additionally, if the templates only represent a subset of the 
particle orientations, this may cause only that subset of views to be chosen and 
thus introduce the corresponding artefacts into the dataset. 
 
2.4.4 Alignment and classification 
In EM, single particle analysis (SPA) is fundamentally an averaging technique, 
conceptually similar to crystallography. While the crystal lattice orients each 
copy of the protein for crystallographers, in EM this alignment and averaging 
must be performed in silico. It is this averaging process that allows the 
extraction of near-atomic resolution information from extremely low contrast, 
low SNR images. The key step is determining the orientation for each 
individual particle and calculating its angular relationship to the other particles 
in the dataset. Particles are then classified based on orientation prior to 
averaging. Several approaches have been used to implement this in alignment 
and classification in 2D including ‘K means classification’, ‘equal distributed K 
means’ and ‘maximum likelihood (ML)’ approaches 
(Sigworth, 1998; Sigworth et al., 2010). This alignment and classification can be 
performed either using user-selected references or in a reference-free manner. 
In reference-based classification the user first selects a series of particles to 
which the dataset is then aligned, often through iterative cross-correlation steps. 
Reference free programs instead act in an unsupervised manner without the 
user defining the initial references. This removes some potential user bias as the 
particles cannot be forced into an incorrect alignment or class by the user. In 
both approaches the user selects the number of classes they require and these 
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are computed based on similarity of the particles and each particle will 
contribute to only the class to which they are assigned. In the ML approach 
each particle will contribute to all classes, with a probability weighting assigned 
to each class so that in practice a particle will contribute strongly to one class or 
a small subset of similar classes and then negligibly to the other classes. This 
weighting can be used to identify particles which do not align well to any class, 
or rather equally well to many classes as this can indicate the particle does not 
represent any particular view and may be contaminant or degraded in some 
way. The advantage of the maximum likelihood approach is the way in which it 
deals with poor quality data. Because SNR is so low in single particle images, 
there is a degree of uncertainty in the orientational assignments. By ‘smearing’ 
the data across many classes, ML approaches can account for some of this error. 
Indeed, for a perfect image with high SNR where orientational assignment and 
classification is perfect, ML would be equivalent or slightly worse than 
traditional one particle, one class approaches. 
 
This classification approach can be expanded to three dimensions and has been 
implemented in several software packages. This can be a particularly powerful 
mechanism for sorting heterogeneous datasets and identifying homogeneous 
subsets suitable for high-resolution refinements. In the ML 3D classification 
within RELION, the user selects the number of desired classes, typically 3-5 
depending on overall particle number, bearing in mind that for asymmetric 
objects a minimum of ~5-10k particles are required to generate a good quality 
3D reconstruction. Initially particles are randomly assigned to a 3D class based 
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upon an initial model leading to a series of subtly different classes. 
Classification then proceeds in an iterative fashion, typically ~25 rounds until 
the classification has stabilised or reached convergence. This classification can 
be repeated on particle subsets which have been thus selected in a hierarchical 
manner, allowing the identification of lowly occupied populations (Fernández 
et al., 2013)(Figure 2.7). In addition, focussed masks can be applied to an area of 
particular interest to discover any subtle variations in this region, which may 
not be observed when considering the entire molecule. 
 
 
Figure 2.7 - Example 3D hierarchical classification. Example of 3D 
classification being used in an iterative fashion from a consensus model to 
identify lowly populated states (boxed in red) within a larger dataset 
(Clouds represent ‘poor’ quality classes). 
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2.4.5 3D reconstruction 
In order to move from a 2D projection or class to a 3D volume, SPA uses 
Fourier slice theorem, which states that for a given object, the Fourier transform 
of a projection represents a central slice through the Fourier transform of the 3D 
object. In order for this approach to be successful, the orientation of each 
projection needs to be estimated prior to reconstruction. How this estimation is 
achieved varies depending upon the software package used. A typical approach 
is projection matching, where a rough starting model is backprojected and then 
compared to the experimental data. This is then used to bootstrap a new model, 
and this process iterated to move away from the starting model. The angular 
assignment can also be carried out in a maximum likelihood manner where, as 
in classification and alignment, the angular assignment is ‘smeared’ across 
several possibilities to account for uncertainty in estimation of the Euler angles. 
As with classification steps, the reconstruction process is iterated several times 
to move away from the starting model towards purely experimental data and 
hopefully convergence. It is also important to note that in most modern 
reconstruction programs the data are split into two independent subsets and 
each refined separately within the program. The agreement between the two 
halves is monitored as a surrogate for resolution which will be discussed in 
more detail below (Section 2.5). 
 
One potential pitfall for users generating 3D reconstructions from EM data is 
model bias. As the SNR of the individual images is very low, it is vital that 
initial models used in the reconstruction process are not only accurate, but are 
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also filtered sufficiently that the high-resolution features of the final map are a 
product of the experimental data rather than simply carried over from the 
starting model. Therefore, the generation of a good starting model is important 
in reconstructions efforts. A common method of generating an accurate starting 
model for a refinement is to use an existing atomic model of the sample derived 
from crystallography. However, this is potentially extremely dangerous, as if 
unfiltered, the high-resolution crystal structure will allow alignment of high 
resolution noise in the dataset, leading to a nominally ‘high-resolution’ result 
that is based on incorrect alignments and is entirely due to model bias. Ideally 
the starting model used would be derived directly from the experimental data 
with little or no input from the user or prior knowledge of the sample. Several 
programs exist that can accomplish this including EMAN2 and SIMPLE-PRIME 
(Elmlund et al., 2013; Tang et al., 2007). EMAN2 for example, works by 
assigning selected classes to a random starting model and checking for 
agreement between the reprojected map and the reference-free 2D classes. 
 
Once the refinement process has finished, the user is left with a 3D volume that 
hopefully represents the experimental data. However, there are still a number 
of steps that can be performed to improve the quality of this map.  The simplest 
of these steps is masking of the final volume to remove background noise so 
that when the Fourier shell correlation (FSC) is calculated (discussed further in 
Section 2.5), only regions corresponding to the sample are compared. This leads 
to removal of noise around the model and potentially a higher reported 
resolution by FSC, as uncorrelated noise will be removed. It is also common for 
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the map to be filtered to the average resolution of the reconstruction as 
determined by FSC, removing high-resolution noise from the final 
reconstruction. Nevertheless, in maps with significant disparities in resolution 
across the volume this can still result in areas containing high-resolution noise 
and small ‘popcorn’ density. To combat this, programs have been developed to 
utilise local resolution measures to filter different areas of the map according to 
the resolution in that region (personal communication Dr CHS Aylett), which 
can lead to a cleaner looking map. 
 
It is often apparent that in the raw reconstruction, a map of a given resolution 
will appear less featured than expected based purely on the resolution value 
given. This is because high-resolution features are often lost due to 
imperfections in the imaging, errors in orientational assignment, and the 
Gaussian blurring of the image giving rise to a B-factor decay of the structure 
factors. In order to regain these features, the high resolution signal must be 
boosted, often called map or B-factor sharpening. While the user can estimate 
an ad hoc B-factor, which is then applied to the reconstruction, this can lead to 
oversharpening where high resolution noise rather than signal is amplified, 
often visually identified through ‘sharp’ and fragmented density. To avoid this 
approaches have been developed that seek to fit the decay of structure factors in 
a given map to a theoretical scattering curve and use a weighting function to 
calculate the appropriate levelling of sharpening required independently of the 
user (Rosenthal and Henderson, 2003). This is unreliable at more modest 
resolutions, requiring <9 Å maps as a minimum. 
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2.4.6 Model building/Flexible fitting 
Even at modest resolutions, EM allows important biological insights to be 
obtained through combining high-resolution structural information obtained 
via other techniques such as crystallography or NMR. Existing structures can be 
rigidly fit into a lower resolution EM map using several tools, the simplest 
being the Fit in Map function within Chimera (Goddard et al., 2007), although 
there are a number of more sophisticated tools including Situs and DockEM 
(Roseman, 2000; Wriggers, 2012). These programs generally work by 
maximising the correlation between the atomic model and the EM map, and 
following this rigid body fit can provide a pseudo-atomic model of a complex 
from multiple atomic models into the EM density. 
 
In maps of higher resolution (< 9 Å), where secondary structure becomes 
visible, it becomes possible to begin to fit atomic models into EM density with 
much greater accuracy at the secondary structure level. This resolution allows 
the model to be flexibly fit into the density rather than simple rigid body fitting. 
While the individual crystal structures will be of higher resolution, often the 
structures of individual subunits are not representative of their organisation in 
the complex as a whole. This can be due to crystal packing artefacts or the result 
of lacking neighbouring subunits within the complex (Rawson et al., 2015). By 
combining lower resolution EM information with high-resolution crystal 
structures it is possible to obtain new insights into complex organisation. There 
are several programs that can be used for flexible fitting including MDFF 
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(Trabuco et al., 2011), FlexEM (Topf et al., 2008) and the relax protocols within 
Rosetta (DiMaio et al., 2015). While each program functions slightly differently, 
one approach is to perform a MD simulation on the input atomic model, 
allowing the protein to relax with a weighting applied to the EM density to 
encourage the model to move into the experimental density. However, at these 
intermediate resolution ranges it is important to avoid overfitting, or 
over-interpreting any deviations observed from the higher resolution structural 
information. 
 
If the EM map obtained is of sufficient quality and resolution (~3.5 Å or better), 
it becomes possible to build an atomic model into the density de novo. There are 
several methods to do this, many adapted from existing crystallography 
programs including Coot for model building and visualisation (Emsley et al., 
2010), Buccaneer (Cowtan, 2006) for initial model generation and REFMAC5 for 
refinement into the EM density map (Brown et al., 2015). In addition, Rosetta 
can attempt to automatically build the entire model into the EM map ab initio 
from only sequence information by breaking the sequence into a series of 
overlapping short segments. The most likely conformations for each short 
segment are predicted and then a search is performed over the entire EM 
volume for the best fit consistent with the location of previously placed 
fragments. This process is then iterated several times with outputs scored based 
on agreement with the EM map and a series of metrics related to likely bond 
geometries and prior knowledge of typical protein structure (DiMaio et al., 
2015; Wang et al., 2015). 
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2.5 Structure analysis/validation 
Unlike light microscopy, the term resolution frequently used in biological EM 
does not refer to a physical property, or the ability to discriminate between two 
nearby points. When used in respect to 3D reconstructions, generally an FSC 
value is referred to as the resolution. FSC is a measure of correlation at a given 
resolution and is typically calculated by splitting the data into two and 
measuring consistency between the halves at each resolution shell. This has 
been an area of intense debate within the field as a map could be entirely wrong 
yet, if self-consistent at high spatial frequencies, would be reported as a 
‘high-resolution’ structure. In addition if the data were processed as a whole 
and only split before the FSC determination, it is possible to introduce spurious 
correlations at resolutions beyond the actual information contained in the data. 
Thus the independent processing of each half is vital (Scheres and Chen, 2012). 
A range of validation steps are required for reconstructions produced at all 
resolution ranges. The value at which the FSC should be measured has also 
been the subject of heated debate within the field, with many studies using a 
correlation cutoff of 0.5 between two half-maps, but a consensus value of 0.143 
correlation has been established. 
 
The resolution determined by FSC refers to the map as a whole, but it is well 
established that biological specimens have some regions better-resolved than 
others. Tools have been developed to calculate this variability in resolution 
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across a map, including ResMap (Kucukelbir et al., 2013). A feature of X Å is 
detected in a voxel by testing for the presence of a X Å sinusoid above the noise 
calculated from the surrounding voxels. This is followed by applying controls 
for false detection and following testing across a range of values of X. The local 
resolution is given as the smallest value of X where the sinusoid is detectable 
above the noise level at a given confidence value. Another way of modelling the 
variability within the sample is through the use of B-factors. In any built or 
fitted atomic model B-factors reflect the uncertainty in the position of any atom 
or residue, and can be obtained during refinement of an atomic model into the 
map. An alternate method of visualising this is through the use of consensus 
models, where the fitted model is used to generate an ensemble of models that 
are then scored against the map prior to a subset undergoing refinement. RMSD 
values between all refined models can then be plotted across the sequence; 
areas with high values are then associated with poor map density and greater 
uncertainty in the position of the atomic co-ordinates. 
 
As previously discussed, EM is particularly vulnerable to reference bias at 
several different steps within the processing pipeline. This can cause the well-
established problem of ‘Einstein from noise’ where a reasonable-looking 
structure is obtained from pure noise due to the incorporation of reference bias 
(Henderson, 2013; Shatsky et al., 2009). The first stage where model bias can be 
introduced is during particle picking, particularly if an automated picking 
program that relies on template matching is used. If a reference containing high 
resolution information, such as one generated from a high-resolution crystal, it 
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is possible that noise images that match these ‘high-resolution’ features will be 
selected. If taken forward, these ‘particles’ will provide a ‘high-resolution’ 
structure of the search template, despite having no basis in reality (van Heel, 
2013). This problem persists into classification steps. For example if a series of 
projections from a crystal structure were used as references then it is likely that 
classes will be obtained that resemble these projections, even if that does not 
represent the actual data. In addition, if a high resolution starting model is used 
for a 3D reconstruction it can heavily bias the resulting structure. Thus starting 
models for initial refinements are heavily filtered to a resolution significantly 
lower than the expected resolution of the map obtained, so that only size and 
gross shape information is left, although if the starting model was produced 
from the data itself then model bias is less of an issue. 
 
The simplest form of validation is the comparison of the classes or raw data to 
the final reconstruction. If several projections of the map have little resemblance 
to reference-free classes or the raw data from which it was obtained, then it is 
likely there is some error in the final reconstruction. Likewise, if many of the 
classes obtained are not found in the projections, this could indicate either a 
mixed population, impurity in the sample, or the presence of start model bias. 
 
A tilt pair test is an additional extension of simply comparing classes/particles 
with projections and is a key tool for validation, particularly for maps at lower 
resolutions. This is achieved by collecting a micrograph at 0° and again at tilt 
angle, often ~30° (Henderson et al., 2011).  The 0° particle from each tilt-pair is 
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compared to projections of the reconstruction to assign initial angles and then 
the tilted particle against the corresponding projection with that tilt applied. 
Over a series of micrographs and particles this agreement can then be plotted 
and the distribution and clustering of this can provide a validation of the 
reconstruction. This process has been added as a module in EMAN2 and there 
is also a web server available (Wasilewski and Rosenthal, 2014). However, this 
can be difficult for samples with very similar views where assignment can be 
challenging, although is still worth doing as a valuable form of validation. 
 
The true gold standard of validation is direct comparison to existing high 
resolution structures of the protein of interest. Indeed it has been argued that 
rather than comparison of two half-maps a better measure of a 3D 
reconstruction would be its correlation to the corresponding atomic model, 
although this is obviously not possible in many cases where either the 
resolution obtained is simply too low or there is no atomic model for 
comparison. If the proper precautions against model bias have been 
undertaken, by strongly filtering any models used, then the appearance of 
chemically-sensible high resolution features itself can serve as part of the 
validation. For example, if the initial model contains no information beyond 
global shape at ~30 Å and the final map shows clear secondary structure 
elements or side chain detail consistent with typical protein structure, it is likely 
these features are truly present in the structure. However, the best form of 
validation still remains common sense, if the structure seems too good to be 
true, it likely is. 
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2.6 Equipment and Materials Used 
All continuous carbon and lacy carbon grids were purchased from Agar 
Scientific and all Quantifoil grids purchased from Quantifoil. All negative stain 
grids were treated under a UV lamp for 20-40 minutes and all cryo grids were 
glow discharged in air for 10-20 s using either a Cressington 208 or a Pelco 
EasiGlow immediately prior to use. All cryo grids were prepared using a 
Vitribot IV (FEI) at nominal 100% humidity and 4°C with a range of blotting 
conditions dependent upon the sample, typically ranging between a blot time of 
3-8 s and a blot force of 3-5, before transfer, under liquid nitrogen (LN2), to 
storage dewars prior to imaging. 
 
The following microscopes were used for this project: 
Microscope Location Voltage (keV) Electron Source Detector 
FEI Tecnai T12 University of Leeds 120 LaB6 Gatan US1000XP CCD 
FEI Tecnai F20 University of Leeds 200 FEG Gatan US4000/SP CCD 
FEI Titan Krios MRC LMB, Cambridge 300 FEG FEI Falcon II DED 
FEI Titan Krios CAS, Beijing 300 FEG FEI Falcon II DED 
Table 2.1 – Electron microscopes and detectors used during the PhD project. 
 
Software Package Function Version(s) 
used 
Buccaneer Automated protein 
chain tracing 
CCP4 7.0020 
Coot Graphics program for 
protein model building 
0.8.6 
CTFFIND Estimation of defocus 3, 4 
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and CTF parameters 
EMAN EM image processing 
suite 
1, 2.1 
gCTF GPU accelerated CTF 
parameter estimation 
0.50 
MDFF Flexible fitting of 
protein structures into 
EM density 
VMD 1.9.1 
MOTIONCORR Whole frame alignment 
and motion correction 
2.0 
RELION Maximum likelihood 
based EM image 
processing suite 
1.3, 1.4 
ResMap Estimation of local 
resolution in EM 
reconstructions 
1.1.4 
Rosetta Modelling software 
suite 
2016.13.58602 
Table 2.2 – Processing software used during the PhD project. 
 
2.6.1 General Image Processing Workflow 
A typical processing workflow for a cryoEM project in this thesis consisted of 
first aligning the raw frames using MOTIONCORR (Li et al., 2013a). CTF 
determination was then carried out using either CTFFIND3, CTFFIND4 within 
the RELION GUI or gCTF (Mindell and Grigorieff, 2003; Rohou and Grigorieff, 
2015; Zhang, 2016). Particles were then picked either manually or automatically 
using the boxer function within EMAN2 and coordinates exported as box files. 
Particles were then inverted, normalised, dust corrected (using typical values of 
3 or 5 sigma for removal of both black and white pixels) and extracted within 
the extract particle module of RELION. 2D classification was then carried out 
  
67 
within RELION, initially the number of classes used was ~(total number of 
particles/200) up to a maximum of ~300 classes. Particles belonging to ‘good’ 
classes were selected by eye and used in a consensus 3D auto-refinement within 
RELION, using a starting model low-pass filtered to ~60 Å. 3D classification in 
RELION was generally trialled at this point using the consensus structure from 
auto-refinement as a starting model.  
 
Depending on results of 3D classification, 2D and 3D classification was then 
iterated until a homogeneous particle stack is found. Following a further 3D 
auto-refinement of this subset, movie frames were then extracted and the 
refinement continued utilising these movie frames. The output _data.star file 
from this process was then used in the particle polishing module of RELION 
using both linear fit of particle movement and damage weighting. The 
calculated B-factors from the damage weighting were then plotted against 
frame number to ensure the B-factors follow the expected damage trend. If the 
plot is highly inconsistent with expected shape (for example a flat line) then the 
particle polishing was re-run omitting the damage weighting with frames to be 
removed specified manually. The ‘shiny’ particles given as an output of particle 
polishing were then re-refined within auto-refinement. Finally the output was 
post processed within RELION. The unfiltered half-maps are masked, using a 
soft mask expanded by around >9 pixels from the model with the initial 
binarisation threshold determined by the noise level of the half-maps. The maps 
were also filtered to the global resolution and have map sharpening applied 
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through either an automatically estimated or ad hoc B-factor in this post 
processing procedure. 
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3. V-ATPase Structure and Mechanism 
 
Structural understanding of the V-ATPase complex has progressed rapidly 
following the widespread adoption of new developments in EM, primarily the 
use of direct electron detectors (DEDs). At the time the following studies were 
carried out, there were no sub nm structures of the V-ATPase, only limited 
structural knowledge of the catalytic states of the full complex and an 
incomplete understanding of the flexibility inherent within the rotary 
mechanism. The work in this chapter aimed to address this lack of information 
through the use of cryo-EM to provide a higher resolution structural model of 
the V-ATPase as well as understand the role flexibility can play in the 
mechanism of the V-ATPase.  
 
3.1 Results and Discussion 
3.1.1 V-ATPase EM Sample Preparation  
V-ATPase complex was obtained from Manduca sexta (M. sexta) midgut and 
kindly provided by the group of Prof. Helmut Wiezorek, University of 
Osnabruck, Germany. M. sexta was used as the protein source as it has several 
advantages over the commonly used yeast system; not only has extensive 
biochemical characterisation been carried out, but as it is a higher eukaryote 
any structural information obtained may be more applicable to therapeutically 
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relevant homologues. For example, the V-ATPase complex from yeast 
apparently lacks the e subunit which is present in the M. sexta sample (Bueler 
and Rubinstein, 2015), and in the Bovine complex. M. sexta V-ATPase is 
sensitive to some selective V-ATPase inhibitors which do not affect the yeast 
complex (Muench et al., 2014a). In addition the midgut of M. sexta is highly 
enriched in the V-ATPase complex, allowing large amounts of protein to be 
purified in a single preparation and by isolating from only a single organ this 
preparation may be enriched with a single isoform of the complex, which 
should reduce heterogeneity and allow for higher resolutions to be obtained. 
However, the use of M. sexta complex does present several disadvantages in 
comparison to the yeast system, chiefly that it is genetically intractable, so 
potentially valuable mutational studies are not possible in the same way. 
 
3.1.2 Cryo Grid Preparation and Optimisation 
Negative stain EM was first used to check sample quality and purity to assess 
for aggregation or degradation before cryo grid optimisation was carried out. 
The sample was checked for the distinctive dumbbell shape side view which is 
commonly observed in negative stain due to a strongly preferred orientation on 
the carbon film. Thus single spherical particles were attributed to belonging to 
degraded or disassociated V1/Vo domains. Screening for grid optimisation was 
performed on an FEI F20 microscope with a Gatan 4K x 4K CCD camera. Initial 
attempts at preparing grids suitable for high resolution cryo-EM studies proved 
unsuccessful with standard lacey carbon grids due to the complex preferentially 
resting on the carbon film and clumping around the edges of the holes rather 
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than distributing evenly. As previous studies, for example on ribosomes,  have 
shown that a thin carbon layer can be used to improve the particle distribution, 
a thin (~10 nm) layer of carbon was placed over the quantifoil support film. 
First carbon was deposited onto a mica surface and this layer then floated onto 
the grids by inserting the mica sheet at a ~45° angle into a water bath containing 
the grids to be coated. Using the previous protein concentration of ~1 mg/ml 
this caused overlapping particles on the grid but acceptable ice thickness. To 
reduce the crowding a dilution with buffer (20 mM Tris-HCl, 9.6 mM 
2-mercaptoethanol, 0.01% C12E10, pH 8.1) of ~20x was used to give a reasonable 
particle distribution (Figure 3.1). 
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Figure 3.1 – Example V-ATPase micrographs. Example cryo micrographs taken 
on a CCD equipped F20 on lacey grids (top), carbon coated quantifoil 
(centre) and carbon coated quantifoil following ~20x dilution (bottom). 
 
High resolution data collection was subsequently carried out on the optimised 
grids at the MRC-LMB using a FEI Titan Krios equipped with a Falcon II direct 
electron detector at a sampling of 1.35 Å/pix and a total dose of ~50 e-/A2 over 
a 2 s exposure with 34 frames in each micrograph ‘movie’. In total 1366 
micrographs were collected using the FEI EPU automated data collection 
software. Micrographs were collected with acceptable particle distribution and 
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minimal drift or astigmatism observed in the Fast Fourier Transforms (FFT) 
(Figure 3.2). 
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Figure 3.2 – Example V-ATPase cryo data.  (A) Example V-ATPase micrograph 
from Krios collected on a Falcon II (Scale bar represents 300 Å). (B) 
Example FFT showing no drift or astigmatism 
 
 
3.1.3 Image Processing 
Whole frame motion correction was carried out on all micrographs using 
MOTIONCORR to minimise the effect of any mechanical drift over the course 
of the exposure and then sum the aligned frames (Li et al., 2013a).  Defocus 
parameters were calculated for the aligned image sums using CTFFIND3; 
micrographs had a defocus range of 1.7-5.5 µm (Mindell and Grigorieff, 2003). 
30730 particles were manually picked in EMAN2 e2boxer before iterative 
rounds of reference free 2D classification in RELION (Figure 3.3) (Scheres, 2012; 
2015; Tang et al., 2007). The classification identified poorly aligned particles 
which were subsequently removed and also identified a large number of 
dissociated Vo and V1 domains, likely due to limited degradation of the sample 
prior to grid preparation (Figure 3.3). Particles belonging to these classes were 
removed leaving 7160 particles. Additionally a well defined class was observed 
with clear 4-fold symmetry which did not correspond to any known V-ATPase 
view and is a contaminant, potentially alpha-ketoacid dehydrogenase complex 
which exhibits a very similar view (Wagenknecht et al., 1990). 
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Figure 3.3 – Representative 2D classes from V-ATPase cryo dataset. 2D V-
ATPase classes from RELION 2D classification showing top, side and high 
angle views. Disassociated V1 side view shown in blue and unknown 
symmetric contaminant shown in green with poorly aligning ‘bad’ 
particles shown in red. 
 
Following 2D classification a 3D auto-refinement was run using a previously 
published V-ATPase reconstruction filtered to 60 Å as a starting model. This  
produced a 12 Å resolution reconstruction, which displayed ‘typical features’ of 
the V-ATPase and clear deviation from the low pass filtered starting model. By 
removing particles based on poor LogLikelihood scores to leave 6714 particles 
the resolution was increased to 11 Å. Finally per particle movie processing was 
then carried out to account for the effects of beam-induced movement during 
the exposure, further increasing the resolution to 9.4 Å by gold standard 0.143 
FSC (Figure 3.4). 3D classification was attempted to identify a more 
homogeneous sub-population, but all reconstructions obtained were of lower 
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resolution following refinement, likely due to the low particle numbers. 
Nevertheless, focussed classifications on the V1 domain did reveal small sub 
populations with the open site apparently located in different positions, similar 
to those observed by Zhao et al in the yeast structures (Zhao et al., 2015). 
However, due to the small particle number these reconstructions were of lower 
overall quality and resolution than the consensus structure. 
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Figure 3.4 – 3D reconstruction of V-ATPase. (A) V-ATPase at 9.4 Å resolution 
viewed from front. (B) Rear view of V-ATPase reconstruction (C) Fourier 
Shell Correlation (FSC) curve showing gold standard (0.143) resolution. 
Figure adapted from (Rawson et al., 2015). 
 
3.1.4 Flexible Fitting of Crystal Structures 
In order to better understand the detailed structure of the V-ATPase complex, 
homology models were generated of each individual subunit in Phyre2 (Kelley 
and Sternberg, 2009; Kelley et al., 2015), with the exception of subunit a where 
insufficient structural information existed at the time of study. These homology 
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models were then used to perform flexible fitting into the whole complex using 
MDFF (Trabuco et al., 2011) to give an optimal fit and, although the resolution 
does not permit accurate positioning of side chains, the Cα positions in the 
secondary structure elements could be approximated with confidence (Figure 
3.5). However, due to the large number of subunits within the V-ATPase 
causing difficulties with the computation, the flexible fitting was carried out in 
sections consisting broadly of the V1 domain and the Vo domain and the two 
halves were then combined.   
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Figure 3.5 – V-ATPase  reconstruction with fitted homology models. Labelled 
M. sexta homology models fitted into 9.4 Å V-ATPase reconstruction with 
MDFF. Inset shows density around H subunit to illustrate quality of fit 
(Trabuco et al., 2011). Figure adapted from (Rawson et al., 2015). 
3.2 Mechanistic insights 
3.2.1 Comparison between yeast and M. sexta V-ATPase structures 
Analysis of the V1 domain clearly shows the open AB dimer to be positioned 
above subunit H within the M. sexta reconstruction, with the remaining two 
sites showing a closed conformation. Importantly, analysis of the ~11 Å yeast 
V-ATPase reconstruction shows the open site to be situated above subunit C 
(Benlekbir et al., 2012), 120° rotated from that of M. sexta. This has significant 
 
 
Vo 
V1 
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implications for understanding the catalytic mechanism of the V-ATPase and 
rotary ATP family as a whole, as comparisons can be made of the rotary motor 
as a whole in two defined catalytic states. One significant feature is that despite 
the two V-ATPase systems being at different stages of their rotary cycle the 3 
stator elements are superimposable (Figure 3.6). From the different 
conformations seen in the stator crystal structures, it has been proposed that the 
cycling between the open, loosely bound and tightly bound states results in a 
change in stator conformation, meaning that as the ATPase cycles the stators 
will accommodate the conformational change within the A/B dimers. Also the 
stators have been proposed to play a role in energy storage, potentially 
compensating for any symmetry mismatch between the V1 and Vo domains. 
 
Figure 3.6 – Superposition of stators from yeast and M. sexta V-ATPase. 
Comparison of stators from yeast V-ATPase (EMDB 2781) in grey mesh 
and M. sexta V-ATPase (EMDB 2781) in green. Figure adapted from 
(Rawson et al., 2015). 
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This change in conformation of the stators would account for the ~7° flexing 
seen directly by EM (see Section 3.2.5), within crystal structures and calculated 
through MD simulations (Oot et al., 2012; Stewart et al., 2012). As the stator 
position appears to be unchanged when comparing the M. sexta complex to the 
yeast system despite apparently being in a different catalytic state, it is likely 
that any deformation of the stators, either for energy storage or to accommodate 
changes in the AB dimers, are transient. Indeed, this comparison suggests that 
the occupancy of the A/B dimer does not dictate the stator position or 
conformation. Thus the conformation of each stator appears to be determined, 
not by the occupancy of the associated A/B dimer but by the contact it makes 
with subunits a, C and H which make up the collar region. Interestingly upon 
inspection, subunit H does not interact with both EG subunits, only subunit E. 
The interface between the H subunit and stator shows a large charged patch 
with a hydrophobic core flanked by a positive and negative patch of residues; it 
is tempting to speculate that this interface plays a role in the apparent mobility 
of subunit H in the isolated V1 domain (Oot et al., 2016). It is also interesting 
that when the structures of all three catalytic states from yeast were compared, 
the authors report small changes in the conformation of the stator network 
depending upon nucleotide occupancy. This discrepancy is likely to be a result 
of the lower resolution of the M. sexta study, or could potentially be a thought-
provoking species difference, highlighting the dangers of extrapolating across 
species. 
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3.2.2 Apparent linkage between subunits d and C 
Key for the rotary mechanism is the need for the central rotor axle to couple to 
the c-ring with no interactions with the static stator complex. However, within 
both the yeast and M. sexta systems this is not the case with significant contact 
made between subunits d and C, observed both directly in the EM 
reconstructions and in the atomic surfaces of fitted atomic models (Benlekbir et 
al., 2012; Rawson et al., 2015; Zhao et al., 2015) (Figure 3.7). The removal of this 
linkage has been shown to increase the flexibility of the system and it was 
hypothesised that this may act in a ratchet like mechanism (Richardson et al., 
2014). In the absence of any ATP hydrolysis this ‘catch’ prevents the axle 
rotating either forwards or in reverse, thus silencing proton leakage and 
preventing futile backwards rotation of the rotor. 
 
Importantly, both yeast and M. sexta V-ATPase complexes show an apparent  
‘resting state’, which based on particle number is the predominant population 
(~47.5% within the yeast system (Zhao et al., 2015)). Interestingly, this coincides 
with the level of interaction between subunit d and subunits C and H, with the 
largest to smallest interfaces having approximately 47.5%, 36% and 16.5% of 
particles associated with them, respectively. This is suggestive that the interface 
may potentially provide stability within the complex, although the exact 
purpose is unknown. One hypothesis could be that this asymmetry in 
population is related to regulation, whereby ATP induces dissociation of the 
complex (Huss and Wieczorek, 2007), so it is possible that the detachment of V1 
from Vo can only occur in certain rotational states and thus is mediated by this 
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interface. Indeed, X-ray studies of the isolated V1 domain which have show this 
domain being consistent with ‘state 2’ from the intact complex.  
 
 
Figure 3.7 – Subunit d interactions. Atomic surfaces from yeast V-ATPase  
subunits d (orange), C (green) and H (pink) showing differences in 
interfaces depending on catalytic state. Figure taken from (Rawson et al., 
2016b). 
 
3.2.3 Electrostatic bearing region 
The mechanism of catalytic cycling within the F/A-ATPase has been well 
characterised through crystal structures of differing states and biophysical 
analysis. However, at the time this work was carried out no crystal structure 
had been reported for a Eukaryotic V1 domain, only that of the related bacterial 
Enterococcus hirae (E. hirae) A/V-ATPase (Arai et al., 2013). A large degree of 
structural conservation is found between the A and V-ATPase ATP hydrolysing 
AB domains especially within those regions directly involved in catalysis 
(Muench et al., 2011). Following flexible fitting of the homology models using 
MDFF, the AB domains were examined. Superposition of the fitted AB 
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structures showed close similarity towards the top of each subunit but a large 
difference at the base, consistent with crystal studies on the open and closed 
states.  This change is focussed within the area equivalent to the DELSEED 
loops of the F-ATPase (Watanabe et al., 2015). Interestingly, a slice through of 
the V1 domain shows that the central rotor axle passes through the central 
cavity in an asymmetric manner making two points of contact with the AB 
domains. The first point of contact is at the ‘DELSEED’ loops, which is expected 
due to their role in applying torque to the rotor axle as part of the mechanical 
function of the complex. However, a second close contact is formed roughly 
two thirds through the structure of the V1 domain, interacting with both the A 
and B subunits (Figure 3.8). The region of interaction is in a highly conserved 
region with a P-A/G-D/E-X-G (subunit A) and P-G/S-R-R/K-G-Y/F (subunit 
B) motif. Analysis of 300 A/V-ATPase sequences within Consurf (Goldenberg 
et al., 2009) shows full conservation of Arg and 95% conservation of Arg/Lys 
within subunit B with full sequence conservation for a negatively charged D/E 
in subunit A. Moreover these loops form a tight hairpin structure which is only 
permitted by the conserved Pro and Ala/Gly that flank the motif. This motif is 
fully conserved between the A- and V-ATPase family and results in a highly 
polar collar of density which alternates between a positive and negative charge. 
The charge faces the highly polar central rotor axle with the highly conserved 
nature potentially suggesting that it performs an important role in ATPase 
function. Interestingly this region is also highly conserved in other rotary 
motors, including the bacterial flagella motor, and the F-ATPase which may 
suggest a more general role for this bearing motif. 
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Figure 3.8 – Electrostatic bearing region in M. sexta V-ATPase V1 domain. (A) 
Section through V1 domain showing fitted subunits A (blue) B (red) and D 
(cyan). (B) Horizontal section of V1 at bearing region. (C) Sequence 
conservation calculated in Consurf ranging from high (pink) to low (black) 
conservation. (D) Electrostatic surfaces calculated in APBS from -5.0 (red) 
to 5.0 (blue). Figure adapted from (Rawson et al., 2015) 
 
The loops regions show little movement in the open and closed states in the E. 
hirae crystal structure, suggesting the loop regions do not operate in manner 
similar to the DELSEED loops. While this feature was identified in the 
F-ATPase complex by Abrahams et al., it was described as a hydrophobic collar 
region and the charged characteristics of these loops were not studied 
A B 
C D 
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(Abrahams et al., 1994). A potential explanation of the alternating charge is to 
form opposing interactions with the central axle allowing it to ‘hover’ within 
the collar structure, reducing drag on the central axle. Thus it is tempting to 
speculate that this bearing may play some role in the extraordinary efficiency of 
the rotary ATPases (Junge et al., 2009). It is also interesting to note that this 
bearing region coincides with the highest resolution elements identified in the 
reconstruction by local resolution assessment in ResMap (Kucukelbir et al., 
2013), indicating its stability within this dynamic motor domain. 
 
3.2.4 d/c-ring interface and subunit e/Ac45 
Another poorly understood feature of the A/V-ATPase family is the ability to 
accommodate different stoichiometries of c-ring, using the same D/d subunits 
and maintaining the same overall architecture. This accommodation can be 
achieved through a striking feature in the reconstruction where the contact 
made between subunit d and the c-ring, ‘socket’ is minimal despite this being an 
interface for torque transmission. By only interfacing with a small surface area 
within the c-ring, rather than plugging the hole in the centre of the c-ring, the d 
subunit will be able to interface with a range of differing c-ring stoichiometries, 
rather like a guide wheel (Figure 3.9). This would explain how the A/V-ATPase 
can adapt to differing symmetries within the c-ring without the need to change 
the d subunit architecture (Meier et al., 2005; Pogoryelov et al., 2005; Vollmar et 
al., 2009). This feature is consistent with the position of the d subunit in yeast 
where its position in all three catalytic states can be observed. However, with 
this highly tilted contact a large hole is visible into the centre of the c-ring, 
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which would need to be plugged in some manner to prevent free diffusion of 
protons and other ions across the membrane. While some studies have 
suggested that lipid plays this role this is a potentially interesting area of 
further research, with new technologies such as styrene maleic acid lipid 
particles (SMALPs) potentially allowing the complex to be imaged in the native 
lipid environment and lipidomics experiments to be performed on the same 
sample (Prabudiansyah et al., 2015).  
 
 
Figure 3.9 – Subunit d/c-ring interface. (A) EM density showing d/c-ring 
interface. (B) Electrostatic surfaces of interface showing areas of 
complementary charge. Figure adapted from (Rawson et al., 2015). 
 
Another prominent feature observed in the Vo domain is an additional density 
at the base of the complex, present within the M. sexta sample but not within the 
yeast reconstructions (Figure 3.10). This protrusion is shown to be glycosylated 
and following treatment of the complex with deglycosylation enzymes this 
density reduces (Rawson et al., 2015). Previous studies have speculated that this 
density is due to the accessory protein ac45, although recent studies suggest 
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that this is not the case as extensive mass spectrometry analysis has been unable 
to identify ac45 within the purified M. sexta sample (Smith et al., 2016). 
Alternatively subunit e has been suggested to make up this density. Subunit e 
has been suggested to be vital for the formation of the c-ring and has been 
shown to be heavily glycosylated and has been identified as part of the purified 
M. sexta complex (Compton et al., 2006; Ludwig et al., 1998; Sambade and Kane, 
2004). However, biochemical studies have suggested that it is not present in the 
yeast complex and is not required for function (Bueler and Rubinstein, 2015), 
explaining the absence of this additional density from the yeast structure. Low 
resolution EM inhibitor binding studies discussed in detail in Chapter 4.2 have 
subsequently supported this theory.  
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Figure 3.10 – Cryo-EM reconstructions of yeast and M. sexta V-ATPase. (A) 
Yeast V-ATPase reconstruction at ~7 Å. (B) M. sexta reconstruction with 
heavily glycosylated protrusion at base denoted by *. Figure taken from 
(Rawson et al., 2016b). 
 
3.2.5 Effect of Flexibility 
Despite the use of a Titan Krios equipped with a DED, the resolution of the 
V-ATPase reconstruction was only a modest 9.4 Å. While this is likely in part 
due to the relatively small dataset collected and the sub-optimal thickness of the 
additional carbon film, resolution estimates of individual micrographs in gCTF 
(Zhang, 2016) suggested that the quality of the data itself was high, with the 
majority of micrographs estimated to have Thon rings extending beyond 3 Å 
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(Figure 3.11). Another potential factor limiting resolution could be sample 
heterogeneity as we were unable to separate the conformational states 
corresponding to the 3 stages of the catalytic cycle. Furthermore several 
previous studies had suggested that the V-ATPase exhibits a degree of 
continuous flexibility in addition to the discrete catalytic states.  
 
Figure 3.11 – Histogram of estimated micrograph resolution. Histogram of 
resolution of each V-ATPase micrograph estimated by gCTF (Zhang, 
2016). 
 
In order to attempt to quantify this flexibility, prior to my involvement in the 
project Dr Chun Feng Song used negative stain EM to assess the level of 
flexibility in the yeast V-ATPase complex. Negative stain was used as it was 
hoped it would simplify the flexibility analysis, as the complex is forced to lie 
flat on the carbon film, and may induce more strained states due to the staining 
procedure, which while potentially introducing artefacts may also allow lowly 
populated flexed states to be observed. In addition it was hoped the higher 
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contrast of negative stain would aid in the processing. Following 2D 
classification in IMAGIC-5 of negatively stained V-ATPase analysis (van Heel et 
al., 1996), through first alignment and classification of the full complex to 
remove poorly aligning or degraded particles followed by alignment and 
masking of each domain individually, showed a large degree of flexibility 
within the sample with flexing up to ~30° observed. While it is possible the 
staining itself induced some of this observed flexing through flattening the 
complex onto the carbon film, a similar feature was observed in cryo-EM classes 
from the same sample (Figure 3.12). I then repeated this work using a larger, 
circular mask alongside the single domain mass to ensure that the observed 
flexing was not an artefact of masks used during the data processing. The same 
feature was observed with the same magnitude of flexing seen in classes 
processed using all masks trialled. 
 
 
Figure 3.12 – V-ATPase 2D flexibility analysis. (A) Negative stain Yeast 
V-ATPase classes (B) Single particle cryo-EM analysis of the M. sexta V-ATPase. 
Figure adapted from (Song et al., 2013). 
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I then investigated the effect of ATP on the flexibility of the V-ATPase complex 
by collecting two additional data sets in the presence or absence of 5mM 
Mg.ATP. All data were collected at the same magnification and processed in the 
same manner, using the same alignment references and mask to ensure that any 
differences seen are related to the addition of ATP and not data processing 
artefacts. The resulting classes for the non-ATP sample showed the same classes 
as generated previously for the M. sexta sample with a number of classes 
showing flexion to a maximum angle of 30°. Interestingly, the addition of ATP 
resulted in the loss of classes that display extreme flexing of V1 relative to Vo 
with only classes displaying a maximum flexion of 10° being seen (Figure 
3.13.B). Approximately 10-20% of ATP-treated particles showed this degree of 
flexion, comparable to that seen in particles without substrate, although this is 
only from a single experiement. 
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Figure 3.13 - The influence of ATP on V-ATPase flexibility. Classes showing 
flexing between V1 and Vo in the absence (A) and presence (B) of 5 mM 
ATP. All data were aligned and classified in IMAGIC-5, using the circular 
mask shown in the top right corner. The scale bar represents 150 Å. Figure 
taken from (Song et al., 2013). 
 
It is also important to consider the role that this flexing motion may play in the 
regulatory mechanism of the V-ATPase. Both the yeast and M. sexta V-ATPase 
have been shown to be regulated through controlled dissociation, whereby the 
V1 domain separates from the Vo domain through a series of currently 
unresolved structural changes. Importantly, the addition of Mg.ATP substrate 
does not increase either the range of the flexion or the proportion of particles 
that are flexed as may have been expected. Instead, it limits the flexibility to a 
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maximum of ~10°, the angle that is most consistent with the proposed bending 
and observed variations in crystal structures of the subunit E/G heterodimer 
(Oot et al., 2012). This more subtle movement is also consistent with the 
predicted flexibility within the V-ATPase from MD simulations (Stewart et al., 
2012). Ion mobility mass spectrometry experiments have also subsequently 
suggested that addition of ATP can reduce conformational flexibility within the 
A-ATPase (Zhou et al., 2014). The larger bending motion is more consistent 
with the large angle flexing seen in the early stage proposed to immediately 
precede disassembly of the Thermus thermophilus A-ATPase (Tani et al., 2013). 
However, it is important to note that the disassembly in the A-ATPase study 
was triggered through large changes in temperature or pH and may not be 
representative of the controlled process of disassociation observed following 
starvation conditions.  
 
As ATP  is required for disassociation (Huss and Wieczorek, 2007), the larger 
bending motion could be due to particles that are primed for disassembly but 
are unable to disassociate due to the lack of ATP. This has important 
implications for crystallographic or further cryo-EM experiments on the rotary 
ATPase family as priming the sample with ATP may allow for a more 
homogeneous sample, allowing higher resolution structures to be obtained. 
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3.2.5.1 3D flexibility and masking 
The highly dynamic V-ATPase mechanism is likely to involve some structural 
flexibility and there is evidence for this in variability between 2D image classes 
from EM as shown in Section 3.2.5, and it is also supported by molecular 
dynamics (Song et al., 2013). Compared to a series of discrete states, the 
continuum nature of flexing makes sorting of the heterogeneity difficult by 
conventional 3D classification. As an alternative, masking based on V1 and Vo 
was investigated to attempt to improve the resolution of the resulting models 
and to asses to what extent this continuous flexibility was impacting the 
obtainable resolution. 
 
2D classification of the previously obtained cryo-EM dataset (see 3.1.2) was 
carried out again in RELION, resulting in 13,083 particles in well defined 
classes. The 3D reconstruction had a tighter mask than previously used for 
these data, which resulted in a global resolution of 9.2 Å, but with a clear 
difference in detail between V1 and Vo, as previously described with helices 
well resolved in the V1 domain, but no secondary structure observed in the Vo 
region. 3D refinement was then carried out separately with the same data stack, 
focussing on V1 and Vo through performing local angular searches based 
around previously determined Euler angles and imposing domain-specific 
masks in RELION (Figure 3.14). Accounting for this flexibility resulted in a 
significant increase in V1 resolution (8.2 Å), with no apparent improvement to 
Vo (~1 nm). 
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Figure 3.14 – Schematic of localised masking procedure. Refinement of 
original 9.4 Å reconstruction (cyan) is carried on with local angular 
sampling and a tight mask imposed (grey) to produce a reconstruction 
taking account of flexibility (purple). Figure taken from (Rawson et al., 
2016c). 
 
Analysis of the masked V1 shows an improved resolution of 8.2 Å, with local 
resolution determination using ResMap (Kucukelbir et al., 2013) showing a 
range from 5 Å to 12 Å, with a significant proportion <7 Å (Figure 3.15). The 
base of V1 shows clear asymmetry with each A/B pair making a different 
interaction with the central rotor axle.  
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Figure 3.15 – ResMap Histogram of masked V1. Histogram generated by 
ResMap showing estimated resolutions of masked V1 domain showing 
large regions of < 7 Å voxels.  
 
The stators show a clear separation of the two α-helices in the masked V1, in 
contrast to the reconstruction obtained masking the whole complex, while the 
highest resolution feature observed was the electrostatic bearing region 
previously identified, with this high stability perhaps suggesting a functional 
role (Figure 3.16). However, the base of the stators becomes poorly resolved, as 
does the central rotor axle and Vo domain when the alignment and 
reconstruction is based on the V1 domain, which indicates flexing between the 
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two domains. Masking of the central region alone resulted in a low quality 
reconstruction, likely due to its small volume. 
 
 
Figure 3.16 – Effect of localised masking on V1 reconstruction. (A & B) Density 
of V1 domain before (cyan) and after (purple) masked refinement. (C & D) 
Slice through V1 density showing improved resolution in core region and 
improved fit of model. (E) Local resolution of V1 domain following 
masked refinement showing highest resolution on core with * denoting 
electrostatic bearing region. (F) Full V-ATPase reconstruction following 
masking showing Vo smearing due to movement. Figure taken from 
(Rawson et al., 2016c). 
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Similar masking of Vo had a negligible effect on the resolution obtained (Figure 
3.17). This could be limited by two factors: firstly heterogeneity within Vo 
caused by rocking of the c-ring, relative to subunit a; alternatively, the smaller 
size of Vo and the presence of bound detergent makes alignment more 
challenging.   
 
 
Figure 3.17 – Effect of localised refinement on Vo domain. (A) Vo domain 
before localised refinement. (B) Vo domain following masking procedure 
showing no improvement in resolution. 
 
Subtle heterogeneity seen in the M. sexta V-ATPase images can be treated by 
masking, resulting in significant resolution improvement. Architectural and 
mechanical similarities across the rotary ATPase family suggest that flexibility 
may also account for resolution differences between the motor and pump 
domains of other systems. The use of masking to identify different 
conformational states in RELION has previously been reported for other 
systems such as the ribosome (Bai et al., 2015b). This work used a similar 
procedure to account for continuous rather than discrete motions in the rotary 
ATPase, which may prove a powerful technique in conjunction with the new 
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technologies and conformational sorting to account for discrete heterogeneity 
within a sample. 
 
Flexion of ~7° about the long axis of the complex has been measured, but the 
precise reasons for this remain uncertain. One possibility is that it may be 
linked to the symmetry mismatch between the 3-fold symmetric ATP motor 
and the variable sized c-ring, necessitating some energy buffering between 
ATPase and proton pump by a flexible rod or spring element. The stator 
filament network could fulfil this function, although recent cryo-EM 3D 
reconstructions show relatively little of the flexing in the different catalytic 
states of the structure. The stator network appears to be relatively rigid, with 
wobble in the motor resulting from conformational changes in the ATPase 
during catalysis being accommodated by flexing of subunits C and a working as 
a ‘torsion spring’ and within the rotor, or by bending at one of the subunit 
couplings. 
 
This flexibility is further shown when other V-ATPase datasets are examined. 
For example, in the yeast V-ATPase reconstructions published by Zhao and 
co-workers over 250k particles were originally identified as V-ATPase but only 
50503, 38347, and 17595 particles were assigned to the final reconstructions 
(Zhao et al., 2015). While many of the particles that were removed are likely to 
have been contaminant or degraded, it is possible that the majority of these data 
represented the complex in the continuum of flexed states. In order to attain the 
side chain resolution now almost routine within the cryo-EM community it may 
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be necessary to mitigate for this flexibility either through addition of additives 
including ATP which may give a more rigid sample of through finding more 
amenable (rigid) systems. Though this raises the question of the value of static 
structural snapshots of what is obviously a highly dynamic complex. 
3.3 Conclusions 
The V-ATPase is a dynamic molecular motor, with significant flexibility and 
movement inherent in its function. This work has shown several important 
features of the V-ATPase mechanism through the production of the first sub nm 
V-ATPase reconstruction via cryo-EM. This reconstruction allowed the fitting of 
homology models for the complete M. sexta V-ATPase apart from the key 
subunit a, involved in proton translocation. 
 
One feature observed following this fitting is an electrostatic collar region in the 
V1 domain, consisting of alternating positive and negative charges in a ring 
around the central rotor axle, which is also the highest resolution region of the 
complex, suggesting a highly stable, functionally important region. While a 
contact between the AB subunits and subunit D in this region had been 
observed previously in the F-ATPase, it was termed a hydrophobic region and 
largely ignored (Abrahams et al., 1994). However, this charged bearing is 
shown to be highly conserved across a large number of species, suggesting it 
may play a functional role within the complex. 
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While other studies have focussed on classifying the various catalytic states of 
the V-ATPase, little attention has been paid to the role of continuous flexibility 
in the mechanism of the complex. Through negative stain analysis this work 
shows that a large amount of flexing is present in a sample of V-ATPase. While 
intuitively the level of flexing may be expected to increase when ATP is added 
and the complex is functioning, when ATP is added only a small amount of 
flexing remains. This is consistent with the theory that ATP is required for 
dissociation and may prove useful if the addition of ATP to ATPase samples 
prior to structural studies this may reduce the flexibility, producing a more 
homogeneous sample, potentially leading to a higher resolution reconstruction. 
 
Flexibility was also examined in 3D cryo reconstructions and partially mitigated 
through a localised refinement procedure, enabling the continuum of flexibility 
to be accounted for resulting in improved resolution in the V1 domain. In 
combination with larger datasets to enable conformational sorting this provides 
another tool to increase the resolution of EM reconstructions and may be 
particularly powerful in cases where continuous flexibility is observed rather 
than a series of defined states. An alternate method for examining this 
continuum of states would be the manifold embedding technique pioneered in 
the Frank group which would allow this continuous motion to be represented 
as a trajectory through the energy landscape and give further insight into the 
mechanical properties of the system (Dashti et al., 2014; Frank and Ourmazd, 
2016). 
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Despite the findings discussed here and subsequent structural studies by 
several other groups, including a number of ~6 Å cryo-EM structures of both 
the V-ATPase and related F- and A-ATPases as well as determination of the 
architecture of subunit a through crystallography and EM studies, there are still 
many unresolved questions in the V-ATPase field. Key among these questions 
is the precise arrangement of subunit a from a high resolution structure, which 
would help to elucidate the mechanism of proton translocation. It is also 
interesting to note the highly unusual horizontal architecture of the a subunit, 
and how this differs from the vertical 4-helical bundle model previously 
proposed and observed in the modest resolution yeast structures (Lau and 
Rubinstein, 2012), though several subsequent studies suggest that this 
horizontal feature is ubiquitous across the rotary ATPase family (Allegretti et 
al., 2015; Morales-Rios et al., 2015; Zhao et al., 2015; Zhou et al., 2015). In 
addition there are several questions still remaining regarding the complex 
mechanisms of regulation within the complex, particularly how ATP silencing 
in the isolated V1 domain is achieved following disassociation, although a 
crystal structure of the intact V1 domain from yeast now suggests that this 
silencing is caused through a structural rearrangement of the H subunit (Oot et 
al., 2016). 
 
This structural work acts to underpin further studies into the mechanisms of 
regulation of the V-ATPase and also forms the starting point for studies into 
V-ATPase inhibition discussed in more detail in Chapter 4.  
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4. V-ATPase Regulation and Inhibition 
  
The V-ATPase can consume a significant proportion of cellular ATP. For 
example, it is estimated to use ~10% of cellular ATP in the M. sexta midgut 
(Huss and Wieczorek, 2007). Thus it is vitally important that its activity can be 
regulated under low ATP conditions such as starvation, to minimise futile ATP 
turnover. The primary method of regulation is reported to be by disassociation 
of the V-ATPase complex, with the soluble ATP hydrolysing V1 domain 
detaching from the membrane bound, proton translocating Vo domain. 
Following this dissociation the Vo domain becomes impermeable to protons and 
ATP hydrolysis no longer occurs in the V1 domain. However, the precise 
mechanism of ATP silencing in the dissociated V1 is poorly characterised and 
understood. By understanding the nature of ATP silencing it may be possible to 
design small molecules that mimic this interaction, resulting in V-ATPase 
inhibition. The current working model is that ATP silencing is a result of a 
rearrangement of the H subunit which contacts the rotor axle, preventing 
rotation and hydrolysis (Figure 4.1) (Jefferies and Forgac, 2008; Oot et al., 2016). 
However, alternative mechanisms have been proposed, such as the movement 
of the terminal helices in subunit F to interact in the AB dimer (Hildenbrand et 
al., 2010; Makyio et al., 2005). If this were the case, then it may be possible to 
target ATP silencing using a helical mimetic. 
 
  
107 
 
Figure 4.1 - V1 schematic illustrating proposed H subunit interaction. (A) 
Surface representation of yeast V1 X-ray structure (PDB 5D80) showing AB 
subunits (red and blue), stator EG subunits (beige), rotor DF (cyan and 
green) and H subunit (purple). (B) Proposed swing of H subunit to contact 
central rotor axle in context of whole complex (grey mesh). Adapted from 
(Muench et al., 2011). 
 
As discussed in Chapter 3, V-ATPase would be an attractive therapeutic target 
for a range of diseases. While several inhibitors of the V-ATPase have already 
been identified, most suffer from a lack of selectivity (Michel et al., 2013), 
particularly the ability to discriminate between different V-ATPase isoforms 
within the body, preventing their use as effective therapeutics. However, Pea 
Albumin 1 subunit b (PA1b) has been shown to display high selectivity against 
the V-ATPase from different weevil populations 
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(Chouabe et al., 2011; Eyraud et al., 2013). It was hoped that understanding the 
mechanism of action that leads to this specificity could inform future efforts to 
design new selective V-ATPase inhibitors. 
 
This work aimed to inform on V-ATPase inhibitor design through two distinct 
approaches. The first was to see if by understanding the structural changes 
necessary for silencing ATP hydrolysis in the V1 domain through cryo-EM these 
changes could be mimicked, thus inhibiting the V-ATPase. This would be a new 
mode of inhibition for the V-ATPase family. The second was to explore the 
mode of action of PA1b with the aim of understanding the basis for selectivity 
and the location of inhibitor binding. This would allow further development of  
existing potent inhibitors which could be altered using this information to 
increase their specificity. 
4.1 V-ATPase Regulation 
4.1.1 Cryo-EM structure of V1 from attached and degraded V-ATPase 
Data for attached and degraded M. sexta V1 samples were obtained from the 
intact V-ATPase cryo grids, prepared and collected as previously described 
(Section 3.1.2). When attached to the full complex, the V1 domain 
reconstructions had a resolution of ~9 Å, which was improved to ~8 Å 
following accounting for flexibility with tightly masked refinements as detailed 
in Section 3.1.2 (Figure 4.2.A).  
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The degraded V1 particles were selected through 2D classification within 
RELION, identifying side views of isolated V1 as well as clear top views. This 
led to the selection of 11701 particles identified as isolated V1. This is an 
imperfect way of selecting the isolated V1 domain as some of the apparent top 
view classes may actually be top views of the entire complex, which would be 
detrimental to any resulting reconstruction. Following 3D auto-refinement and 
particle polishing of this particle set within RELION a ~9 Å reconstruction was 
obtained (Figure 4.2.B). However, care must be taken when interpreting the 
reconstruction obtained from the degraded V1 sample. Not only is it possible 
that particles belonging to the intact complex remain in the data, it is also 
inherently a damaged and degraded sample, which is likely to not be fully 
representative of any natural regulation or dissociation. 
 
 
Figure 4.2 - 3D reconstructions of V1 attached to the V-ATPase and degraded. 
(A) V1 domain of the V-ATPase at ~8 Å resolution. (B) V1 domain from 
degraded V-ATPase particles at ~9 Å resolution. 
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Nevertheless, some initial insights can be gained from looking at this structure 
in comparison with the attached complex. Most noticeable is the lack of density 
corresponding to subunit H, despite this subunit being heavily linked with ATP 
silencing by biochemical and X-ray studies (Jefferies and Forgac, 2008; Oot et 
al., 2016; Parra et al., 2000). This was thought likely to be a result of degradation 
within the sample rather than showing a different mechanism for regulation. 
Interestingly, despite the sample not being the result of ‘natural’ dissociation 
the overall position and architecture of the AB subunits that make up the core 
of the V1 domain is very similar to that of the attached, intact V1 domain. This 
suggests that, even following this detachment, there are no large scale structural 
changes within the core of the particle. 
 
4.1.2 Cryo-EM structure of V1 from disassociated V-ATPase  
4.1.2.1 V1 Sample Preparation 
Isolated V1 (~1 mg/ml in 20 mM Tris–HCl and 100 mM NaCl, pH 7.9) from 
M. sexta midgut was kindly provided by the group of Prof. Helmut Wiezorek, 
University of Osnabruck, Germany. V1 was detached from the V-ATPase 
complex and purified as described in Muench et al 2014 (Muench et al., 2014b; 
Vitavska et al., 2003). As the midgut is isolated during the molt stage of larval 
development, it is enriched in naturally dissociated V1 (Gräf et al., 1996), 
because the glucose levels in the larva drop sharply prior the beginning of the 
molt stage (Siegert, 1995). Moreover, since they do not eat at this stage, the 
midgut V-ATPase is not required to regulate the pH within the midgut lumen 
for leaf digestion. 
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4.1.2.2 Cryo Grid Preparation and Optimisation 
Prior to cryo grid preparation the V1 sample was first assessed for sample 
quality and purity as well as  aggregation or degradation by negative stain EM. 
Grids were UV treated for ~30 mins immediately prior to use and stained using 
uranyl acetate. The grids were screened on the in-house Technai T12 
microscope, operating at 120 kV and at a nominal magnification of 30k. This 
showed homogeneous particles with little aggregation and no obvious 
degradation (Figure 4.3). Cryo grid preparation was carried out on an FEI 
vitribot IV according to standard procedures using lacey grids which had been 
glow-discharged for 30 s prior to use with blot times varying between 4 and 6 s.  
These were screened using a FEI F20 microscope equipped with a Gatan 4K x 
4K CCD camera. Grids showed reasonable particle distribution, with acceptable 
ice thickness, although particles were observed to cluster around the edges of 
the holes. 
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Figure 4.3 - V1 negative stain micrograph. Negative stain micrograph of 
dissociated V1 at 50k magnification. 
 
Data were collected in a semi-automated fashion using SerialEM at the Chinese 
Academy of Sciences, Beijing on a FEI Titan Krios equipped with a Falcon II 
camera. 986 micrographs consisting of 32 frames each were collected at a total 
dose of ~60 e-/Å2 over 2 s at 1.76 Å/pixel sampling (Figure 4.4).  
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Figure 4.4 - Dissociated V1 cryo-EM raw data. (A) Cryo micrograph of 
dissociated V1 (scale bar 500 Å). (B) Reference free class averages of V1 
showing clear top and side views. (C) Estimated resolution of micrographs 
from gCTF. 
 
4.1.2.3 Image Processing 
Whole-frame motion correction was carried out on all micrographs using 
MOTIONCORR (Li et al., 2013a) and defocus parameters calculated with 
CTFFIND4 in the first instance (Rohou and Grigorieff, 2015), with micrographs 
having a defocus range of ~2-4 µm. 43326 particles were manually picked in 
EMAN2 (Bell et al., 2016; Tang et al., 2007), prior to 2D classification within 
RELION (Scheres, 2012). Well-defined classes showing the characteristic top 
view of the V1 domain were observed as well as side views with clear AB 
domains and some stator density (Figure 4.4.B). Particles belonging to 
poorly-defined classes were removed to leave 29905 particles. 3D auto-
refinement of this subset led to a 8.1 Å reconstruction, which was improved to 
7.5 Å following per particle motion correction and polishing within RELION. A 
further resolution improvement to 7.0 Å was obtained through per particle 
defocus determination through gCTF (Zhang, 2016). 
 
4.1.3 Results and Discussion 
The final 7.0 Å reconstruction of V1 is consistent with the previous cryo-EM 
studies of the domain, clearly showing the position of the open site (Muench et 
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al., 2014b). The improved resolution allows secondary structure to be identified, 
with the helices in the core of the region well-defined (Figure 4.5). However, in 
contrast to the previous cryo-EM study, stator density was poor in the final 
map, with only one stator being clearly visible. 
 
 
Figure 4.5 - Dissociated V1 structure. (A) Side view of dissociated V1 
reconstruction at 7 Å, facing open site, showing a stator well resolved on 
the right of the complex. (B) Top view of the V1 domain. (C) Slice through 
the core of V1 domain around electrostatic-bearing region showing helical 
secondary structure well-resolved. 
 
The most notable feature of both the 2D classes and the 3D reconstruction is the 
lack of any density for the H subunit thought to be responsible for ATP 
silencing within V1. While this feature was not previously observed within M. 
sexta V1, it has been detected in a crystal structure from the yeast complex (Oot 
et al., 2016). Whereas in the previous M. sexta model the lack of subunit H 
density could be attributed potentially to the low resolution, the current 7 Å 
reconstruction is very comparable to the 6.5 Å crystal structure. Indeed, once 
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phase bias is accounted for, it could be argued that a 7 Å EM reconstruction 
would be superior in quality to a 6-7 Å X-ray map. Indeed a 6.5 Å structure is in 
the bottom ~0.1% of all structures in the PDB by resolution. The 7 Å EM map 
clearly shows secondary structure resolved within the AB subunits, and local 
resolution estimates that portions of the reconstruction extend to ~6 Å (Figure 
4.6). 
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Figure 4.6 - Dissociated V1 local resolution. (A) 3D reconstruction of 
dissociated V1 coloured by local resolution calculated by ResMap 
(Kucukelbir et al., 2013). (B) Histogram showing voxels assigned to each 
resolution bin. 
 
As the H subunit is thought to be crucial for silencing of ATP hydrolysis the V1 
crystal structure, which had a defined position for subunit H, was filtered to 30 
Å and used as a starting model for 3D classification (Figure 4.7). This would 
check if there was a subset of particles where subunit H could be observed by 
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giving it the extra density to align with. It should be noted that this is not 
normally a sensible approach, as it could add bias into the model, but it does 
indicate whether the subunit may be present. However, no well-defined 3D 
classes were obtained with any density corresponding to the H subunit. In 
addition the X-ray model was used as a starting model for the auto-refinement 
procedure in an attempt to bias the reconstruction towards the H subunit, but 
again the resulting reconstruction at 7.5 Å showed no signs of the H subunit 
(reconstruction not shown). 
 
 
Figure 4.7 - Biased 3D classification of V1. Results of 3D classification within 
RELION using a filtered crystal structure (PDB 5D80) (grey) start model 
(Oot et al., 2016). Additional density at base corresponding to subunit H 
was not observed within any resulting class. 
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Subunit H was present in the V1 sample used to prepare the cryo grids and has 
been observed on gels (data not shown). Previous work on the V1 domain also 
showed that the H subunit is present in gels and negative stain classes of V1 
(Muench et al., 2014b). To test that this was not sample-specific, the negative 
stain grids that were made on the same day as the cryo samples were re-
analysed and data collected under my supervision by Rachel Johnson, a PhD 
student in the group. In total 181 micrographs were collected at a nominal 
magnification of 50k resulting in 15218 particles.  Reference-free classification in 
RELION resulted in classes that showed clear additional density at the base 
corresponding with the location of V1 (Figure 4.8). This observation may be due 
to the surface tension forces of the stain, forcing H into a single defined position 
or limiting its movement. Without this stabilising interaction, the H subunit 
may be mobile and thus when captured in vitreous ice will be in a range of 
positions and therefore lost in the averaging process.  
 
  
120 
 
Figure 4.8 - Negative stain V1 class averages. Class averages of V1 showing 
extra density at base of several classes, corresponding to location of H 
subunit. Data processing carried out by Rachel Johnson. 
 
It is important to note that, in the X-ray structure subunit H makes extensive 
crystal contacts with neighbouring subunits, which may mirror the stabilising 
effect of the stain pressing onto the carbon film (Figure 4.9). Thus, while the 
interaction between H and the central rotor axle, shown by X-ray studies and 
cross linking experiments may indeed occur, it is likely transient interaction 
rather than a stable interaction based on the EM data.  
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Figure 4.9 - H subunit crystal packing. Crystal packing around the H subunit 
in V1 X-ray structure (PDB 5D80) (Oot et al., 2016). H subunit (blue) packs 
against the central axle subunit D (red) and EG stators and H subunits 
from neighbouring molecules (cyan). 
 
As only limited stator density was observed in the EM reconstruction and no 
subunits were visible in the collar region, it is possible that the alignment of the 
V1 domain is dominated by the position of the open site. Thus subunit H could 
become rotationally averaged across the three different positions. However, if 
this were the case, some smeared density from subunit H in three positions 
should be visible around the  base of the V1 domain, but nothing was observed 
even at high contour levels. Also when using the X-ray starting model, subunit 
H was more prominent than the position of the open site and thus would be 
expected to ‘lock in’ the alignment on this feature. The X-ray study also 
suggested that isolated V1 was only present in one conformational state, 
corresponding to the ‘state 2’ in yeast (Oot et al., 2016; Zhao et al., 2015). As the 
EM reconstruction lacks any rotor or collar density it is not possible to say 
which state the M. sexta V1 structure is residing in. The H subunit is ~55 kDa 
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which given the overall mass of V1 (550kDa), means it makes up ~10% of the 
structure. Given other examples in the literature (Bai et al., 2015b; Hesketh et al., 
2015), it would be expected that a mass of this size would be observed through 
3D classification if present in a stable position. 
 
4.1.3.1 Comparison of V1 models 
If the H subunit was not playing a role in ATP silencing, the next step was to 
assess if there were any clear differences between the different V1 domains. 
Although this could not be done at the atomic level, the resolution was 
sufficient to be able to see large conformational changes in the secondary 
structure. To accomplish this, MDFF (McGreevy et al., 2016; Trabuco et al., 
2011) was used to flexibly fit homology models of the AB subunits (generated in 
Phyre2 (Kelley et al., 2015)) into each map in turn using the approach described 
previously (Section 3.1.4). The fitted models were then split into single AB pairs 
corresponding to the open, loose and tight sites. AB pairs corresponding to each 
site were then overlaid using the MatchMaker and MatchAlign tools within 
Chimera (Meng et al., 2006). Backbone RMSD values were then calculated 
within Chimera and plotted onto the secondary structure to attempt to show an 
objective measure of difference between the fitted models. 
 
It is worth noting that only minimal changes are observed in the AB subunits of 
V1, with the fitted models from the three states (attached, dissociated and 
degraded) all showing very similar backbone positions within the maps. The 
majority of changes between the attached and dissociated AB subunits are 
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located at the base of the open site (Figure 4.10). However, it is not obvious how 
these small shifts would cause ATP silencing to occur. While there are some 
differences in the EM maps in this region, due to the modest resolution of the 
EM reconstructions, these minor differences could be a result of errors within 
the fitting, particularly in loop and terminal regions. 
 
 
Figure 4.10 - Differences in AB pairs between dissociated and attached V1. 
Fitted atomic models of AB pairs from each state coloured by backbone 
RMSD values between the dissociated and attached structures. Large 
differences are concentrated at the base of the open site. 
 
While not directly relating to regulation, several other features are apparent 
within the reconstruction, notably the lack of density for two out of the three 
stators. This could be the result of degradation of the sample (although it is 
unclear why one stator would remain relatively intact), an image processing 
artefact, or an indication that these regions are highly mobile within the sample. 
As it is known that collar subunit C is lost from V1 upon dissociation, it is 
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possible that the two stators that contact this subunit become more mobile 
following its removal and that they are therefore not visible in the 
reconstruction. Additionally it is interesting to note that the density for the 
central rotor axle subunit D becomes weak in the central cavity in the lower 
portion of V1, near the ‘DELSEED’ loop region (Figure 4.11). This suggests that 
removal of the connection between V1 and Vo causes this region to become 
mobile, with subunit D only held rigidly around the electrostatic bearing region 
previously described (Section 3.2.3). This also re-enforces the theory that no 
stable interaction with the H subunit is present, as this would be predicted to 
stabilise the position of the central rotor axle.  
 
 
Figure 4.11 - Comparison of rotor axle density between dissociated and 
attached V1. (A) Central slice through dissociated V1 reconstruction 
showing lack of density for rotor axle in the central cavity towards the 
base. (B) Rotor axle density in attached V1 domain. (C) Overlay of 
dissociated (blue) and attached (grey mesh). 
 
One interesting and potentially worrying possibility is that the wrong question 
is being asked. Is the dissociated sample obtained from ATP starved organisms, 
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either yeast or M. sexta, actually relevant? If the reconstruction from this 
supposedly natural dissociated form is compared with that from a specimen 
obtained from degradation of intact V-ATPase in vitro, very few differences are 
observed in the fitted models. Indeed the AB subunits are almost identical aside 
from minor differences primarily centred around loop and terminal regions, 
suggesting that there is little or no difference between V1 that has undergone 
‘natural’ dissociation and V1 which has dissociated in vitro without any prior 
regulatory signal and so is assumed to be ‘degraded’ (Figure 4.12). A further 
speculative theory is that the V-ATPase is in equilibrium between apparent 
‘dissociated’ and full complex, with cellular signals simply shifting this 
equilibrium towards a more dissociated state. This would explain why the 
‘natural’ V1 domain and the ‘degraded’ V1 domain are identical in structure at 
the resolution studied. Its interesting to note that it was the idea that both 
domains dissociate was originally based upon studies showing that tagged 
subunit C diffuses away from the membrane upon starvation (Sumner et al., 
1995; Vitavska et al., 2003). However a recent study by the same group showed 
that labelling of the A subunit does not result in a loss of signal at the 
membrane (Tabke et al., 2014). This suggests the V1 domain is never truly 
dissociated from the membrane in M. sexta, implying that the actual process of 
regulation and ATP silencing is potentially more complex and subtle than 
simply breaking the V-ATPase complex in two. This is perhaps unsurprising 
given that previous studies have shown that while ATP turnover is silenced in 
starvation conditions, in order to disassemble the complex ATP is in fact 
required (Huss and Wieczorek, 2007).  
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Figure 4.12 -  Comparison of degraded and dissociated models. Comparison of 
atomic models flexibly fitted into both dissociated and degraded domains 
coloured by RMSD. Minimal differences are seen in each AB pair. 
 
An additional concern is knowing where the V1 sample was obtained in the 
‘lifetime’ of the complex. While it is assumed that the V1 is obtained results 
from dissociation and degradation, it is possible that a proportion of this 
sample was actually from newly assembled V1, which has not yet been coupled 
with Vo to form an intact complex, and may be regulated in a different manner 
entirely. However, this is less likely as it is known that glucose starvation 
induces the dissociation of the V-ATPase and due to the larval stage at which V1 
is isolated being depleted in glucose it is assumed that the majority of free V1 is 
a result of this process (Gräf et al., 1996; Siegert, 1995). It is also important to 
note that the full complex is purified by size exclusion chromatography and so 
no free V1 should be purified at the same time (Huss et al., 2002; Rawson et al., 
2015). Therefore any V1 found in the sample as ‘degraded’ cannot be newly 
assembled V1. 
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So the question remains: what is the cause of ATP silencing following 
dissociation of the V1 domain? As the EM reconstructions show no sign of the 
expected rearrangement of the H subunit, perhaps ATP silencing is a result of a 
more subtle change in the structure of V1. However this would require 
obtaining higher resolution structures than those currently available of both the 
intact complex and the dissociated V1 domain. Subunit F was also proposed as 
an alternate possibility for the regulation of V1, but this is not observed in either 
the X-Ray or EM structures, so this seems unlikely to be the case (Hildenbrand 
et al., 2010; Makyio et al., 2005). It is also possible that the regulation of the 
V-ATPase differs across species, which would explain the differences in the M. 
sexta and yeast structures. This would be potentially unsurprising as several 
aspects of dissociation apparently differ between the two systems, with M. sexta 
V1 not thought to move from the membrane while the yeast is thought to 
completely dissociate. Given that no clear structural change was observed to 
trigger ATP silencing, unfortunately this work did not provide any potential 
inhibitor binding sites. Nevertheless, it has shown that the simple picture of 
dissociation as a mechanism for silencing ATP turnover may be more complex 
than was previously thought. 
 
Negative stain data collection of V1 at 50k magnification and classification was 
carried under my supervision by a PhD student in the group, Rachel Johnson, 
who also aided in preparation of the V1 homology models in Phyre2 and 
subsequent fitting in MDFF with my supervision. 
  
128 
 
4.2 V-ATPase Inhibition 
The V-ATPase is a potentially attractive therapeutic target for a number of 
disease states including cancer invasiveness and osteopetrosis. However, the 
lack of selectivity in existing V-ATPase inhibitors precludes its development 
into a viable drug target. This work aims to understand the basis of selectivity 
for a plant toxin which inhibits the V-ATPase in a selective manner with the aim 
of using this to inform future efforts in therapeutic developments against this 
target. 
  
4.2.1 V-ATPase inhibition by PA1b 
Pea albumin 1 subunit b (PA1b) is a 37-residue peptide isolated from pea plants 
(Jouvensal et al., 2003). Incorporating three disulfide bridges, it displays a high 
degree of stability (Figure 4.13) (Da Silva et al., 2009; Eyraud et al., 2013; 
Jouvensal et al., 2003). 
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Figure 4.13 – PA1b sequence and structure. (A) PA1b sequence with disulfide 
bridges shown. (B) PA1b structure (PDB: 1P8B) with disulphide bridges 
shown in cyan. Figure adapted from (Muench et al., 2014a). 
 
In plants it is produced as a natural insecticide, acting to kill weevils. Its toxic 
effect was found to be through the inhibition of the V-ATPase complexes of 
these species (Chouabe et al., 2011; Gressent et al., 2007). In contrast to the 
majority of other V-ATPase inhibitors, PA1b displays high levels of specificity; 
for example, it shows no inhibition of the V-ATPase from yeast or humans and 
it is even highly selective among different weevils, which show little sequence 
variation (Gressent et al., 2007; 2011). However, its precise binding location on 
the complex was unknown as was its mode of action. Although it was known to 
bind to the membrane bound Vo domain and thus could access this domain 
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directly from the insect gut. At the time this work was carried out DEDs were 
not yet widely in use, thus the realistic resolution obtainable for the V-ATPase 
was in the region of 11-16 Å. Therefore, negative stain EM was used to rapidly 
identify the binding site of PA1b on the V-ATPase complex due to its ease and 
speed as the expected resolution gain from cryo-EM was not thought likely to 
provide much additional information.  
 
4.2.1.1 Sample preparation and data collection 
The PA1b sample was kindly provided by Dr Frédéric Gressent at Université de 
Lyon, France, while V-ATPase was provided by the group of Prof. Helmut 
Wiezorek, University of Osnabruck, Germany as previously described (Chapter 
3). The resolution typically obtainable through negative stain EM is 15-25 Å, 
thus the small PA1b toxin would likely be too small to directly observe using 
this technique (Figure 4.14).  
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Figure 4.14 - V-ATPase and PA1b size comparison. Size comparison of 
V-ATPase (grey) and PA1b toxin (circled in red). PDB: 1P8B (Jouvensal et 
al., 2003) EMDB: 2781 
 
To combat this, the PA1b was first conjugated via a biotin tag to a 
streptavidin-functionalised horseradish peroxidase (Strep-HRP) in order to 
increase the steric bulk and bring the total size of the inhibitor from ~4 kDa to 
~100 kDa. To check if conjugation with biotin had a detrimental effect on 
inhibition, binding studies were carried out by Dr Markus Huss, University of 
Osnabruck, Germany, which showed no overall changes to the binding affinity 
following the addition of the biotin tag (Figure 4.15), with Ki of 6.5 ± 1.13 nM for 
PA1b and 5.4 ± 6.6 nM for PA1b-biotin. 
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Figure 4.15 - Binding curves of PA1b ±  biotin tag. Binding curved carried out 
by Dr Markus Huss showing no differences between PA1b binding after 
addition of biotin tag. Figure adapted from (Muench et al., 2014a). 
 
All negative stain grids were prepared according to standard procedures using 
continuous carbon-coated grids that had been UV treated for ~30 minutes prior 
to use. Data were then collected using a FEI Technai T12 microscope equipped 
with a 2k CCD camera (Figure 4.16). 527 and 841 micrographs were collected 
for the PA1b and PA1b + ATP samples, respectively. 
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Figure 4.16 - Negative stain micrograph of V-ATPase + tagged PA1b. Example 
micrograph of V-ATPase + PA1b dataset showing reasonable particle 
distribution. 
 
4.2.1.2 Results and Discussion 
Prior to my involvement in this project preliminary studies had been carried 
out by Dr Stephen Muench who collected an initial five datasets and controls 
used to confirm PA1b binding. To avoid any bias within the data processing 
five samples were initially collected, V-ATPase alone, V-ATPase + Strep-HRP-
PA1b (conjugated for 1 hour), V-ATPase + PA1b, V-ATPase + Strep-HRP and 
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V-ATPase + Strep-HRP + PA1b (not pre conjugated). Each of these was made 
by Dr Clair Phillips and labelled anonymously so that all data were collected 
and processed ‘blind’.  All data were picked in EMAN and the reference-free 
classification was done in IMAGIC-5. Following classification, only the samples 
containing both PA1b and Strep-HRP showed any additional density. 
Following this I prepared all subsequent grids and performed all imaging and 
image processing. 
 
A further 527 micrographs of the V-ATPase with the pre-incubated Strep-HRP 
tagged PA1b were then collected, leading to 10056 particles (Figure 4.16). 
Following reference-free classification within IMAGIC-5 the classes clearly 
showed an additional density at the base of the Vo domain of the V-ATPase 
(van Heel et al., 1996) (Figure 4.17).  
 
 
Figure 4.17 - Negative stain classes ± PA1b.  (A) Apo V-ATPase negative stain 
classes. (B) V-ATPase + PA1b classes, arrow denotes additional PA1b 
density (scale bar 150 Å). Figure adapted from (Muench et al., 2014a). 
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Following an asymmetric 3D refinement within the refine module of EMAN, a 
3D model was obtained showing an arc of density extending ~100° around the 
base of Vo (Ludtke et al., 1999) (Figure 4.18). At the time the study was carried 
out, 3D classification was not routine, thus no effort was made to separate out 
separate bound states within the data. 
 
 
Figure 4.18 - 3D reconstructions ± PA1b. (A) 3D reconstruction of apo 
V-ATPase. (B) 3D reconstruction of V-ATPase + PA1b showing additional 
density in arc at base of Vo domain. Figure adapted from (Muench et al., 
2014a). 
 
The binding location suggested that the inhibitor was binding to the c-ring of 
Vo, which would be consistent with the binding location of many previously 
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identified inhibitors, including bafilomycin (Osteresch et al., 2012; Wang et al., 
2005). These c-ring binders are thought to act as a ‘spanner in the works’ by 
binding to the c-ring, being rotated during the complex’s normal activity, and 
then preventing further rotation when they reach the c/a subunit interface 
(Wang et al., 2005) (Figure 4.19). If this were the case, then upon addition of 
ATP to the sample the additional density would be expected to localise to a 
single point at the base of the Vo domain, consistent with the location of the c/a 
subunit interface. 
 
 
Figure 4.19 - PA1b expected mechanism schematic. Schematic of expected 
PA1b mechanism with PA1b (green) bound to c-ring (cyan) driven into 
subunit a (red) by rotation of the c-ring. 
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To test if PA1b was operating via this mode of action ATP was added to the 
sample, negative stain grids were prepared and the data collection repeated, 
leading to 841 micrographs containing 11341 particles. Upon classification in 
IMAGIC-5, additional density was again observed at the base of Vo. 3D 
refinement in EMAN showed clear density at the base, approximately the 
correct size for a single bound PA1b-Strep-HRP, localised to a single point as 
expected. However, instead of being positioned at the c/a subunit interface, the 
density appeared to be localised ~90° away (Figure 4.20). This was an 
unexpected result, showing that PA1b acts on the V-ATPase through a novel 
mechanism. Efforts were made to bias the resulting reconstructions through the 
use of starting models containing a smear of density for the +ATP set and a 
localised density for the –ATP dataset but in both cases no difference was found 
in the final result. 
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Figure 4.20 - V-ATPase and PA1b + ATP. (A) 3D reconstruction of V-ATPase + 
PA1b + ATP showing localised density at base of Vo. (B) 2D classes 
showing additional density at the base of the V-ATPase. (C) Comparison 
of PA1b binding +ATP (red) and -ATP (cyan). Figure adapted from 
(Muench et al., 2014a). 
 
In order to further examine the reason for the unexplained binding location, 
photoaffinity labelling studies were carried out by Dr Markus Huss, Osnabruck, 
using radiolabelled PA1b-benzophenone. This showed that binding appeared 
to be to the subunits making up the c-ring, as expected, but also to subunit e 
(Figure 4.21). This finding was particularly interesting as the location of subunit 
e within the V-ATPase complex was not known at the time, as it is expected to 
be disordered and heavily glycosylated, making structural studies extremely 
challenging. The binding location of PA1b suggests that subunit e is positioned 
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at the base of Vo, distant from subunit a, although the modest resolution 
obtained does not allow any further interpretation of the precise location of the 
subunit. 
 
 
Figure 4.21 - PA1b radiolabelling data. Radiolabelling analysis performed by 
Dr Markus Huss. (A) SDS-PAGE showing V-ATPase subunits following 
labelling with 125I-PA1b with slice numbers used for scintillation counting. 
(B) Scintillation counting against slice number showing majority of counts 
in bands corresponding to subunits c and e. Figure adapted from (Muench 
et al., 2014a). 
 
The binding to subunit e may be the basis of PA1b’s selectivity. For example, it 
has been suggested that subunit e is not present in the purified yeast complex, 
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which may explain why PA1b has no effect (Bueler and Rubinstein, 2015). If this 
is the case it may enable the development of specific V-ATPase inhibitors by 
targeting these non-conserved subunits. However, currently subunit e is 
unlikely to be an attractive target for future inhibitors, as very little is currently 
known about it. While this work has identified its rough location within the 
complex, its precise location is still not well-established, nor are its structure or 
function within the V-ATPase. It would perhaps be beneficial to perform 
cryo-EM studies on PA1b binding as recent advances would allow the binding 
site to be determined with much greater accuracy. This would also potentially 
shed further light on the position and function of subunit e within the V-ATPase 
complex. 
 
4.3 Conclusions 
The V-ATPase is involved in a large range of disease states including cancer 
invasiveness and osteopetrosis and as such has been a long-sought-after 
therapeutic target. To investigate this further, two approaches were used. The 
first was to investigate the structural changes that accommodate ATP silencing 
of the V-ATPase during glucose starvation to see if they could be mimicked by 
small molecules. The second was to develop our understanding of the species 
specific inhibitor PA1b, to characterise the basis of its selectivity, which is 
currently the biggest hurdle in V-ATPase inhibitor development.  
 
  
141 
To explore the structural changes that trigger this silencing in isolated V1, 
cryo-EM reconstructions were obtained of V1 in naturally dissociated state and 
compared to similar resolution reconstructions of the V1 domain in the intact 
complex. The current theory in the field suggests that a rearrangement of 
subunit H is responsible for ATP silencing (Jefferies and Forgac, 2008; Oot et al., 
2016), and is supported by biochemical and X-ray data. However, the cryo-EM 
reconstructions show no density corresponding to this subunit. Biochemical 
and negative stain analysis both show that subunit H is present within the 
sample used for the EM studies, suggesting that subunit H is highly flexible and 
any interaction with the rotor axle must be transient. Unfortunately, while small 
changes in the AB subunits were observed between the attached and 
dissociated state, they were not sufficient to explain the silencing.  
 
In addition, a cryo-EM reconstruction of V1 from in vitro degraded V-ATPase 
was compared to the dissociated sample. This showed only minor differences 
between the two isolated V1 structures, potentially suggesting that the 
dissociated sample does not fully represent the physiologically relevant state of 
the protein. 
 
Together, this work suggests that the H subunit rearrangement is possibly 
either only present in lower Eukaryotes or does not fully explain this process. 
Moreover, the role of silencing during association is also poorly understood and 
often overlooked when studying ‘isolated’ domains. Although this work does 
not provide any firm conclusions on the exact cause, it does provide evidence 
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that a simple structural rearrangement is not the cause. Unfortunately no new 
insights into a possible site for inhibition were generated, but understanding 
function and mechanism is essential if new therapeutics are to be developed.  
 
In addition to identifying new inhibitor binding sites, a second important aspect 
of drug design is understanding the mode of action of existing inhibitors, so 
that this insight can be incorporated into future drug design efforts. To this end 
the binding site of a selective V-ATPase inhibitor, PA1b, was investigated 
through negative stain EM. This used a novel tagging approach for EM studies, 
which permitted the identification of PA1b at the base of the Vo domain, which 
in conjunction with radiolabelling showed the inhibitor bound to the c-ring and 
subunit e. This work also showed the approximate location of e within the 
complex for the first time. This showed the utility of even low resolution EM 
studies to rapidly identify inhibitor binding sites before carrying out more 
detailed, focussed studies on the area of interest. 
 
Although this work did not provide any new V-ATPase inhibitors, it has 
provided insight into the mechanism of V-ATPase regulation, which could 
prove valuable in future efforts to identify novel inhibitors. It also 
demonstrated the utility of low resolution tagging techniques to rapidly 
identify inhibitor binding sites, which can be used to guide future structural 
characterisation through co-crystallization for example.  
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5. Visualising Inhibitor Binding using EM 
 
The technical advances occurring in the field of cryo-electron microscopy (cryo-
EM) have resulted in the resolution expectations for single particle EM 
reconstructions being significantly improved from the identification of 
secondary structural elements, to the resolving of side chain positions (Bai et al., 
2015a; Vinothkumar and Henderson, 2016). For example, the number of sub 4 Å 
structures in EMDB has grown from 32 to 112 in recent years (Kühlbrandt, 
2014). This improvement in resolution has opened the door to a host of new 
research directions driven by single particle cryo-EM experiments. One such 
example is structure-based inhibitor design, a field previously underpinned by 
X-ray crystallography. However, the recent step change in the capabilities of 
EM, has seen cryo-EM used to determine the structure of the TRPA1, TRPV1, β-
galactosidase, human p97 and the proteasome in complex with their respective 
inhibitors (Bartesaghi et al., 2015; da Fonseca and Morris, 2015; Gao et al., 2016; 
Li et al., 2016; Merk et al., 2016; Paulsen et al., 2015). In the majority of these 
cases high-resolution X-ray crystallographic data were used as a foundation to 
build atomic models within the EM map. 
 
The versatility of EM for large protein complexes, which are often intractable to 
crystallization, makes it advantageous over traditional routes for 
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structure-guided drug design in a number of areas. Structural biology can 
underpin ligand design and it is becoming clear that with advances in EM, 
obtaining the structure of previously intractable systems is now possible. 
 
5.1 IGPD Structural Studies 
Imidazoleglycerol-phosphate dehydratase (IGPD) is an essential enzyme 
complex, found in both plants and microorganisms, that catalyzes the sixth step 
in histidine biosynthesis, where dehydration of imidazoleglycerol-phosphate 
(IGP) occurs to form imidazoleacetol-phosphate (IAP) (Bisson et al., 2015; 
Gohda et al., 1998) (Figure 5.1). The ~565 kDa catalytically active 24-mer, which 
exhibits 432 symmetry, is formed from inactive trimers of the apo-protein upon 
addition of Mn2+ (Hawkes et al., 1995; Petersen et al., 1997; Tada et al., 1995; 
Wilkinson et al., 1995).  Given that histidine is synthesized de novo by plants, 
IGPD is an attractive target for herbicides that act after the emergence of the 
crop, for which there are presently a limited number of biological targets. For 
this reason IGPD is currently being studied as a new herbicide target.  
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Figure 5.1 - Histidine biosynthesis pathway. Schematic of histidine 
biosynthesis pathway with IGPD and HPP highlighted. Based on (Ingle et 
al., 2005). 
 
IGPD was used as a model system to study inhibitor binding via EM due to its 
high symmetry and stability, both of which were hoped to aid in obtaining the 
resolutions required to directly visualise inhibitor binding and allow de novo 
model building. In addition, the availability of highly potent (nM) inhibitors 
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was hoped to minimise issues relating to binding site occupancy, thus aiding in 
locating the inhibitor within the complex. Finally, access to high-resolution 
crystal structures allowed validation of any binding observed to give 
confidence in any results obtained (Bisson et al., 2015) (personal communication 
Dr. Claudine Bisson, Sheffield). 
 
5.1.1 EM Structure of IGPD 
IGPD protein from Arabidopsis thaliana (At) and (2hydroxy-3-[1,2,4]triazole-l-yl-
propyl)-phosphonic acid inhibitor was kindly provided by Dr. Claudine Bisson 
from the University of Sheffield. Cryo grids were prepared in a standard 
manner using Quantifoil 2.2 grids, which were glow discharged for 30 seconds 
before use. Following this, 3 µl of protein/inhibitor complex in buffer (50 mM 
Bis-Tris propane buffer pH 8.0, 50 mM NaCl, 10 mM β-mercaptoethanol, and 
0.4 mM MnCl2) was added at ~0.5 mg/ml concentration and the grid blotted 
and frozen using a Vitribot mark IV (FEI) according to general methods 
(Chapter 2). Grids were initially screened on a F20 equipped with a CCD 
camera operating at 60k magnification. The resulting micrographs showed a 
closely packed distribution with several characteristic square views 
predominating, as well as other views in areas with thicker ice towards the 
edges of the holes. Indeed the particles formed semi-ordered layers readily in 
the ice layer towards the centre of the holes where the ice was thinnest (Figure 
5.2). Initially a small number (57) of micrographs were collected and picked 
semi-automatically using the EMAN2 swarm tool. This dataset of 19351 
particles led to a very low resolution cube like structure when processed within 
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RELION using octahedral symmetry, potentially due to difficulties in alignment 
of the smooth, relatively unfeatured structure as previously observed in 
apoferritin EM studies (Figure 5.2) (Henderson and McMullan, 2013; Russo and 
Passmore, 2014). Additionally, the particles were likely too closely packed due 
to the magnification used, although recent studies have shown even extremely 
closely packed particles can achieve high resolution (Liu et al., 2016).  
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Figure 5.2 – IGPD data from CCD-equipped F20.  (A) Micrograph of IGPD 
taken on a F20 equipped with a CCD (scale bar 200 Å). (B) 3D 
reconstruction of IGPD showing low-resolution features and no detail. 
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Following this, a new data set was collected (~80 micrographs) of the same 
batch of IGPD grids on the same F20 fitted with a K2 DED at 1.8 Å/pixel 
sampling. The micrograph quality was noticeably higher using the K2 camera, 
with more detail observed within individual particles (Figure 5.3). Following 
whole-frame motion correction using MOTIONCORR, 3049 particles were 
picked. After refinement of the particle stack using the known crystal structure 
filtered to 40 Å as the starting model, the resulting structure from RELION was 
post-processed using a mask extending 9 pixels from the model and a 6.6 Å 
resolution reconstruction was obtained. This showed clear density 
corresponding to α-helices following B-factor sharpening using an ad hoc 
B-factor of -350. This was in good agreement with the existing crystal structure 
of the complex, although this resolution was too low to identify any bound 
inhibitor. Particle polishing of this small dataset led to no improvement in 
resolution. 3D classification was also trialled, leading to a 2538 particle subset, 
but following refinement of these data no improvement in resolution was 
observed and the resulting map appeared of slightly lower quality. Automated 
particle picking using the swarm tool within EMAN2 was also trialled to 
increase the particle number, leading to 33614 particles picked initially. 
However, 2D classification showed many neighbouring particles in the classes 
and following further classification no improvement was made in the resulting 
reconstructions. 
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Figure 5.3 - IGPD from F20 equipped with a K2 DED. (A) Micrograph of IGPD 
taken on a F20 equipped with a K2 DED, scale bar represents 50 nm. (B) 
3D reconstruction of IGPD showing secondary structure with flat β-sheets 
observed on the surface. 
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It is interesting to note the dramatic effect of motion correction on the quality of 
the data obtained using the K2-equipped F20. When the same particle co-
ordinates are extracted from non-motion-corrected micrographs, the resulting 
classes and reconstruction lose all detail, with no secondary structure. Indeed, 
the resulting reconstruction appears similar to the CCD reconstruction obtained 
on the same microscope (Figure 5.4). 
 
 
Figure 5.4 - Comparison of aligned and unaligned micrographs. (A) 3D 
reconstruction using aligned K2 frames and associated classes (C). (B) 3D 
reconstruction using unaligned K2 frames and associated classes (D). 
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To push the resolution further, a final dataset was collected using the same 
grids on a Titan Krios equipped with a Falcon II DED at the Chinese Academy 
of Sciences, Beijing using SerialEM to collect the data in an automated fashion 
(Mastronarde, 2005). 682 micrographs at 1.10 Å/pixel sampling were obtained 
with intentional variation in the area of the hole imaged in order to capture a 
wider range of views in the thicker ice towards the hole edges (Figure 5.5.A).  
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Figure 5.5 - IGPD data from Titan Krios. (A) Motion-corrected micrograph 
from Titan Krios IGPD dataset showing thicker ice and wider distribution 
of views towards the edge of the hole (scale bar 300 Å). (B) 2D class 
averages from these data showing clear detail but limited views. (C) 
Estimated resolution of the micrographs following motion correction with 
majority <4 Å.  
 
Following semi-automated picking using the swarm tool and manual culling to 
remove particles too closely packed,  110977 particles were obtained. 2D 
classification within RELION resulted in well-defined classes (Figure 5.5.B), 
although views were still limited and poorly aligned classes or classes showing 
density from neighbouring particles were then removed to leave 83466 
particles. At this point a 3D refinement gave a reconstruction at 3.8 Å 
resolution, showing clear separation of β-sheets and larger bulky sidechains. 
This dataset was then subjected to further rounds of 2D and 3D classification 
leaving 55481 particles. Following per-particle motion correction in RELION’s 
particle polishing utility and removing all but frames 5-18 (~27 e-/Å2 total dose 
received), the resolution was improved to ~3.4 Å. Frames were removed rather 
than weighted, as upon inspection of the estimated per-frame B-factors, the 
expected initial sharp rise and then a steady fall in B-factor was not observed, 
indicating the weighting was likely incorrect (Figure 5.6.A).  
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Figure 5.6 – B-factor plots of IGPD data. B-factor plots of IGPD data using no 
frame averaging (A) showing no clear trend, and 5 frame rolling average 
(B) giving expected decay curve. 
 
By increasing the number of frames averaged to calculate the B-factor, the 
expected curve was obtained though this reduces the accuracy of the weighting 
(Figure 5.6.B). By removing further frames, leaving only frames 3-9 (~14 e-/Å2 
total dose) the resolution was again improved to ~3.2 Å, causing side chains to 
be clearly visible. With the rapid developments within the EM field new 
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programs are constantly becoming available that permit small gains in 
resolution. An example of this is gCTF which can calculate defocus on a 
per-particle basis (Zhang, 2016). This may potentially mitigate any changes in 
defocus across the micrograph due to the grid not being flat or subtle 
differences in the particles z-position within the ice layer. The subsequent use of 
gCTF produced a small increase in resolution to ~3.1 Å although no clear 
differences between the maps were visible.  
 
By using three different camera/microscope combinations several IGPD 
reconstructions were solved across a wide resolution range, illustrating the 
power of new developments in microscope stability and crucially the role of 
DEDs (Figure 5.7). 
 
 
Figure 5.7 - IGPD comparison. Comparison of IGPD reconstructions from CCD 
camera on F20 (left), K2 on F20 (centre) and Titan Krios with a Falcon II 
(right). 
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5.1.2 IGPD Model Building and Fitting 
Initially the existing crystal structure of IGPD was flexibly fitted into the ~6.6 Å 
IGPD map using MDFF (Trabuco et al., 2011). Secondary structure showed 
good agreement between the map and model, with α-helical regions clearly 
defined and the model was clearly traceable through the map. 
 
To demonstrate how EM can be a powerful tool for the determination of ligand-
protein complexes of unknown structure, de novo model building was 
conducted in Buccaneer and Coot using the IGPD 3.4 Å EM map (Cowtan, 2006; 
Emsley et al., 2010). To reduce computational time, the map was segmented in 
Chimera to isolate one of the 24 subunits, guided by the clear density of the 
external β-sheet. Buccaneer was run on the segmented map, with the resulting 
model clearly identifying four helical components and 6 β-strands (Figure 5.8).  
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Figure 5.8 - Map segmentation and initial Buccaneer build. (A) Segmented 
monomer density used for the model building. (B) Initial model obtained 
from Buccaneer showing some helices assigned with several breaks in 
connectivity. (C) Example of automatically built model positioned 
backwards. (D) Example of poorly fitting automatically assigned 
sidechain. 
 
Independently density-guided de novo model building was carried out within 
Rosetta3 (DiMaio et al., 2015; Wang et al., 2015). This process consists of 
breaking the full sequence into a series of overlapping short fragments, based 
on the common conformations these short sequences are known to adopt. These 
fragments are then placed into the density and scored. This process is then 
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iterated using the positions of highly-scoring fragments to guide the placement 
of subsequent parts based upon the sequence. Finally a consensus map is 
created from these assembled and scored fragments, which can then be used for 
further iterations or manual building/refinement. In the first instance, this 
produced a consensus model containing the four core α-helices with side chains 
appearing well-matched to the density. Following several iterations of the 
process one of the four-strand β-sheets was also well-placed within the density 
by reducing the search space through subtracting the previously built model 
from the EM density (Figure 5.9). 
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Figure 5.9 – De novo model building within Rosetta. (A) Initial round of 
Rosetta building showing core helices mostly assigned. (B) Third round of 
iterative Rosetta assignment with β-sheets starting to be built. (C) β-sheet 
density remaining following subtraction of built model from experimental 
density to reduce fragment search space. (D) Rosetta model following 5 
rounds of building with core helices and one β-sheet well assigned.  
 
Both models from Buccaneer and Rosetta3 corresponded well with the 
predicted secondary structure as calculated in Phyre2 (Kelley et al., 2015), 
independently of the known crystal structure. Visual inspection in Coot was 
subsequently used to edit clear errors in the initial model produced by 
Buccaneer, such as poor chain tracing and connectivity errors (Figure 5.10.A). 
Several areas of the sequence also appeared to be placed backwards into the 
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density meaning extensive rebuilding was required. The sequence was assigned 
in Coot using both the EM side chain density and predicted secondary structure 
as a guide, although loop regions and the outer β-sheet proved challenging to 
model with confidence. The resulting model contained two β-sheets, flanking a 
four-helical bundle (Figure 5.10.B). Analysis of the bond angles and 
Ramachandran plot showed good overall geometry (~93% favourable, ~5% 
allowed, ~2% outlier). 
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Figure 5.10 - Refined IGPD model and representative density. (A) 
Automatically built model from Buccaneer. (B) Refined monomer from 
REFMAC5 showing correct connectivity and assigned secondary structure. 
(C) Refined complex model into complete map. (D) Representative density 
following REFMAC5 refinement showing clear side chain density(Brown 
et al., 2015; Murshudov et al., 2011). 
 
5.1.3 IGPD Inhibitor Docking and Visualisation 
To identify any regions of unexplained density within the IGPD map, which 
might account for the bound inhibitor, the built model was filtered to 3.5 Å and 
a difference map between the 3.5 Å EM map and the AtIGPD2 de novo built 
model was generated within Chimera using the ‘vop subtract’ command. 
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Strong positive density in the difference map was located within the dimer 
interface with weaker density flanking this region (Figure 5.11). This weaker 
feature in the difference map represents the C-terminal region of the 
polypeptide, identified after comparison to the X-ray crystal structure, 
discussed in Section 5.1.4. 
 
 
Figure 5.11 - Use of difference density to identify inhibitor binding site. 
Difference density (green) between symmetrised built model and 
experimental density showing good agreement with the size and shape of 
the bound inhibitor. 
 
Strong density is seen in both the cryo-EM map and difference map within the 
heart of the dimer interface, which is flanked by a number of His residues at the 
top of the pocket and positively charged residues at the base. Calculation of the 
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local resolution in Resmap (Kucukelbir et al., 2013), showed this region of 
positive density to be one of the higher resolution areas within the 
reconstruction, at approximately 2.6 Å local resolution. Therefore a new map 
was generated which was filtered to 2.6 Å and used to analyse the region of 
unaccounted-for density. Contouring of this map showed two strong density 
peaks within the pocket ~2.5 Å away from the histidine residues within the 
binding pocket (Figure 5.12), features consistent with the manganese ions that 
co-purify with the protein. However, it is not possible to unambiguously assign 
these density peaks to manganese in a standard EM experiment, although 
complimentary techniques including scanning transmission electron 
microscopy (STEM) could be used to identify the locations of metal ions and 
electron energy loss spectroscopy (EELS) or energy-dispersive X-ray 
spectroscopy (EDX) could be utilised to show the elements present. Thus 
biochemical information relating to the role of the Mn2+, known co-ordination 
geometry and distances  are required to assign this density. 
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Figure 5.12 - Inhibitor binding site with Mn2+ density peaks. Inhibitor binding 
site showing fit of refined atomic model (blue) into experimental density 
(grey). Additional density from EM density map filtered to 2.6 Å shown in 
mesh is in good agreement with Mn2+ positions. 
 
After fitting the metal ions, the remaining density was sufficient to 
accommodate the triazole-phosphonate inhibitor, with the three ring nitrogens 
occupying a position within the coordination sphere of each of the bound metal 
ions (Figure 5.12).  Moreover, the map showed strong density consistent with 
the negatively charged phosphate group of the triazole-phosphonate inhibitor, 
which is located within a cavity surrounded by the positively charged residues 
(Figure 5.13.B). However, the resolution was not sufficient to assign the pose or 
stereochemistry of the inhibitor, but was sufficient to assign the approximate 
orientation and location. To further investigate the finding in silico molecular 
docking using SymBiosis’ eHiTs software was performed by Dr Martin 
  
166 
McPhillie as a form of map-independent validation, using only the de novo built 
model and no information from the EM map (Zsoldos et al., 2007). The docking 
for the S-isomer was consistent with that of the manually-modelled inhibitor 
within IGPD, with the top-ranked pose suitably positioned for the trizole group 
for interaction with two Mn2+ ions, and the phosphate with the positively 
charged pocket. The docked inhibitor was also in good agreement with the EM 
density, despite this not being used as a constraint during the docking protocol.  
 
 
Figure 5.13 - Position of inhibitor within EM density. Refined atomic model 
and inhibitor (blue) shown in EM density (grey mesh). (A) Triazole ring of 
inhibitor positioned so coordination with Mn2+ is maintained. (B) 
Phosphonate moiety of inhibitor positioned in close proximity to 
positively charged sidechains giving confidence to assigned inhibitor pose. 
 
The fit of the in silico docked inhibitor within the EM density, which was not 
used as a constraint within the docking program, gave a clear validation of the 
results. As such, even in structures where the resolution does not allow the 
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unambiguous determination of the inhibitor pose, valuable information can be 
extracted through an integrated approach utilising computational docking. 
 
Following initial model building in Coot, and addition of the fitted ligand with 
co-ordinating Mn2+ into the model, refinement of the model into the map was 
then carried out in REFMAC5 (Brown et al., 2015; Murshudov et al., 2011). 
Initially, refinement was carried out on a monomer, into the segmented 
monomer density used for the initial building. However, this did not properly 
reflect the co-ordination of the bound inhibitor at the interface between 
monomers. Thus refinement was performed using a symmetrised initial model 
into the full experimental map by Daniel Hurdiss, a rotation student under my 
supervision (Figure 5.10.C). Following refinement on the whole complex a 
R-factor of 0.39 was obtained and the inhibitor co-ordination well placed with 
respect to the surrounding histidine and Mn2+. 
 
5.1.4 Validation and comparison to X-Ray Structures 
The resulting structure was validated by comparing it to a 1.1 Å X-ray crystal 
structure of the same complex (PDB 5EKW). Overall the two structures agree 
very well, with an overall RMSD value of 0.73 Å. Minor differences of ~1 Å 
RMSD are concentrated within the loop and terminal regions (Figure 5.14). This 
could be reflective of the minor changes seen between a protein in the 
crystalline state and the frozen hydrated state in cryo-EM, as well as errors in 
the model building due to the modest resolution. 
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Figure 5.14 - Comparison between crystal and EM models. (A) Superposition 
of crystal structure (PDB 5EKW) (gold) and EM derived model (blue) 
showing good general agreement between the models. (B) IGPD model 
coloured by C-α RMSD showing the majority of differences are 
concentrated in terminal or loop regions.  
 
Comparisons of the inhibitor binding region show high similarities with 
regards to the positioning and co-ordination of the bound inhibitor (Figure 
5.15). Minor differences are seen between the two structures within the binding 
site, with minor shifts of the inhibitor and bound Mn2+. These differences are 
most likely due to the disparity in resolutions. However, it is possible that this 
is through subtle differences within the EM map compared to the crystal 
structure, and not the modelling of IGPD or fitting of the inhibitor.  
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Figure 5.15 - Comparison of binding sites in EM and X-ray models. 
Comparison of crystal structure (PDB 5EKW) (gold) and EM derived 
model (blue) showing minor differences in inhibitor pose despite near 
identical sidechain positions. However, rotomers cannot be accurately 
assigned due to the resolution of the EM density.  
 
Another possible cause of the difference in inhibitor position is the level of 
radiation damage in both structures. As in EM negative side chains are known 
to degrade even after extremely low electron doses (Allegretti et al., 2014; Grant 
and Grigorieff, 2015), the model that is actually obtained is actually a 
high-resolution structure of a damaged, potentially altered protein. Indeed, 
when viewed at the same contour level, negatively-charged side chains within 
the map are much weaker than the aliphatic or aromatics ones, though when a 
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reconstruction is produced from a lower dose subset of the data, some of this 
density does return (Figure 5.16). This differential damage may explain the 
subtle shifts in the inhibitor position as two Glu (E77 and E173) residues are 
present in the binding site, potentially stabilising the Mn2+. In the EM structure 
there is little density for these side chains, so movement/damage could cause a 
shift in the Mn position, in turn shifting the inhibitor, which is co-ordinated by 
these ions. 
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Figure 5.16 - Comparison of side chains at varying dose levels. Comparison of 
negatively charged side chain D117 density (grey mesh) from 
reconstructions using frames 5-18 (~ 27 e-/Å2 total dose) and frames 3-9 
(~14 e-/Å2 total dose). F147 shown as reference for contour level used and 
general side chain density. 
 
However, it is worth nothing that there are no major changes in the density 
around the inhibitor binding site (Figure 5.17). The lower dose map shows the 
same overall pocket of density for the inhibitor, although the density for the 
phosphonate group is perhaps slightly stronger. 
 
  
172 
 
Figure 5.17 - Comparison of inhibitor binding site at varying dose levels. (A) 
Inhibitor binding site with density in grey at higher dose showing minimal 
difference from the lower dose map (B). 
 
The crystal structures of IGPD have shown that the C-terminal 15 residues form 
a loop that closes down on the substrate (or inhibitor) as they bind, which is 
disordered in the unbound form (Bisson et al., 2015). There is clear density 
around this region in the EM map (Figure 5.18) and the corresponding 
difference map, but it is not of sufficient quality to permit the unambiguous 
modelling of this region, and likely represents a more mobile area of the 
structure (Bisson et al., 2015). While 3D classification was carried out on the 
IGPD data set, this binding loop was not subjected to focussed classification, so 
it is possible that a subset of particles exists with a more ordered loop region. 
Both the crystal structure and EM structure were solved in the presence of a 
mix of R and S forms of the inhibitor, which surprisingly display similar 
binding affinities (Bisson et al., 2016). Within the crystal structure this results in 
little difference in the position of the triazole or phosphate groups but does 
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result in changes to the C3 position and hydroxyl group, though the resolution 
of the EM map does not allow this subtle change to be observed.   
 
 
Figure 5.18 - Terminal differences between X-ray and EM IGPD models. 
Comparison between X-ray (PDB 5EKW) (gold) and EM (blue) C-terminal 
loop region of IGPD model showing additional residues built into X-ray 
map. 
 
Initial image processing of the Titan Krios dataset and refinement of the 
resulting atomic model (with assistance from Garib Murshadov) was carried 
out under my supervision by a rotation student, Daniel Hurdiss. Inhibitor 
docking was carried out by Dr Martin McPhillie, Leeds. 
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5.2 HisB Structural Study 
While in plants IGPD is expressed as a single protein that catalyses the 6th step 
in histidine biosynthesis, in E. coli a fusion protein is used. This larger complex 
(~900 kDa), HisB, combines the C-terminal (residues 167-355) IGPD core (6th 
stage of the pathway) with a N-terminal (residues 1-166) histidinol phosphatase 
(HP) domain, which carries out the 8th step in histidine biosynthesis (Figure 
5.1) and is suggested to still form a 24-mer (Rangarajan et al., 2006). Although 
high-resolution crystal structures of the IGPD core and the truncated HP 
domains are available (PDB 2FPU) (Rangarajan et al., 2006), the larger HisB 
complex has proven challenging for X-ray crystallography studies since well 
diffracting crystals could not be obtained. As such, this protein was studied via 
EM in order to decipher the arrangement of the HP domains and to compare 
the IGPD core structure with the known plant homologue which has ~50% 
sequence identity (Rangarajan et al., 2006). The ability to differentiate between 
the plant and bacterial IGPD complex may provide insights into the design of 
more selective inhibitors. 
 
5.2.1 HisB Structure 
HisB protein samples were provided by Dr. Claudine Bisson at the University 
of Sheffield and the quality of sample assessed via negative stain EM. Briefly, 
grids were made by applying ~20 µg/ml HisB protein (2mM MnCl2, 0.1M KCl, 
50mM Hepes pH 7.5) onto a glow-discharged carbon-coated grid which was 
subsequently negatively stained as described in Section 4.1.2.2. Grids were 
assessed on a Technai T12 microscope, fitted with a 2k Gatan CCD and 
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operating at a nominal magnification of 30k. The protein appeared relatively 
monodisperse and homogeneous, although some aggregation was seen, and as 
such was taken into cryo studies (Figure 5.19).  
 
 
Figure 5.19 -  Representative negative stain micrograph of HisB. Negative 
stain micrograph of HisB showing individual particles with minimal 
aggregation. 
 
Grids were prepared using standard methods (Chapter 1.6) on 2:2 quantifoil 
grids following 30 s glow discharge using a Vitribot IV and screened using a 
F20 equipped with a CCD. Again the protein appeared relatively 
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well-distributed and monodisperse. Data collection was then carried out using 
a Titan Krios equipped with a Falcon II at LMB Cambridge. 843 micrographs 
were collected at 1.35 Å/pixel sampling over a 2 s exposure spread across 34 
frames (Figure 5.20).  
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Figure 5.20 - HisB raw data from Titan Krios. (A) Motion-corrected 
micrograph of HisB collected on Falcon II equipped Titan Krios with 
example particles boxed in red (scale bar 400 Å). (B) Reference-free 2D 
classes of HisB showing characteristic IGPD square core with additional 
less well-defined density on corners. 
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Whole frame motion correction carried out in MOTIONCORR and manual 
particle picking was then carried out in EMAN2 and CTF parameters estimated 
in CTFFIND3. Initial particle picking gave 35654 particles. An initial model with 
octahedral symmetry was obtained in EMAN2 following 2D classification and 
used for initial 3D refinement within RELION. Following iterative rounds of 2D 
and 3D classification to remove particles belonging to poorly defined classes, 
the particle number was reduced to 15765, and a reconstruction at 6.9 Å 
resolution was obtained. The resolution was then increased to 6.7 Å following 
the RELION particle polishing procedure. Again, upon inspection the B-factor 
plots showed a random distribution, suggesting there was not enough signal in 
a single frame to robustly estimate B-factors. Frames 5-18 were then used in the 
reconstruction process with no B-factor weighting applied resulting in a  6.4 Å 
reconstruction. ResMap and localfsc showed a strong variability in local 
resolution across the complex (Cardone et al., 2013), the IGPD core having large 
regions of ~4-5 Å density and the peripheral HP domains at a much lower 
resolution of ~7-10 Å (Figure 5.21). This is likely a result of heterogeneity and 
flexibility in the HP domain, indeed similar smearing of mobile peripheral 
features has been observed in other systems including pyruvate dehydrogenase 
(Milne et al., 2002). 
 
  
179 
 
Figure 5.21 - Local Resolution of HisB reconstruction. Local resolution of HisB 
complex calculated in ResMap showing well-resolved core and poorly 
defined peripheral domains on the corners, seen as a surface (left) and a 
slice through section (right) 
 
The IGPD core was then masked and re-refined using only small local searches 
in the procedure previously used for the V-ATPase (Section 3.2.5). Following 
this focussed refinement, a IGPD core structure was obtained at 4.5 Å resolution 
following post processing. In this map β-sheet separation was beginning to 
appear as expected at this resolution range. The resolution in this region 
suggests that the IGPD core is not significantly destabilised in the fusion protein 
relative to the isolated core enzyme, and that the overall resolution of the 
complex is being severely affected by the highly mobile HP domains (Figure 
5.22). 
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Figure 5.22 - Local resolution of HisB core domain following masking and 
focused refinement. (A & B) IGPD core of HisB coloured by local 
resolution values from ResMap following focussed refinement of the core 
domain. (C) Segmented monomer with fitted atomic model showing 
β-strands beginning to resolve. 
 
However, focussed classification and refinement of the HP domain did not lead 
to any noticeable improvement in this region, with no additional detail 
observed and resolution values ~10-15 Å in these areas. As previously 
discussed in Section 3.2.5, this could be due to the degree of heterogeneity in 
these domains in addition to any flexibility between the core and this region. 
 
Signal subtraction as developed in the γ-secretase study (Bai et al., 2015b) was 
also trialled on both the IGPD core and the HP peripheral domains. Following 
subtraction of the HP domains, no alternate conformations of the IGPD core 
were observed and a reconstruction of the core region led to a 5.1 Å 
reconstruction similar to the reconstruction obtained from masked refinement. 
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However, no improvement was observed to the HP domain density following 
this procedure and no alternate conformations were observed. It is also worth 
noting that when a starting model lacking density for the HP domains was 
provided, density for these peripheral domains returned following the 
refinement procedure. 
 
5.2.1.1 Organisation of HP domain 
Previous crystallography studies had shown the HP domain as a dimer 
(Rangarajan et al., 2006), with the protein also existing as a dimer in solution. 
Thus the HP domain was assumed to lie as a dimer along the twofold edge of 
the cube-like core. However, reference-free 2D classification clearly showed that 
additional density was observed on the corners of the central cube. As there are 
three copies of the IGPD core making up this vertex, with the termini nearby it 
is clear that this dimer model is incorrect, with a trimer forming instead. 
Following reconstruction with octahedral symmetry imposed there was a clear 
addition of a three-fold density at each corner of the IGPD core when compared 
to the plant IGPD structure (Figure 5.23). As the HisB protein is a fusion protein 
of the IGPD monomer and the HP enzyme, the position of three IGPD termini 
on the corner of the complex means there has to be three copies of the HP 
domain present. The size and shape of this additional density is consistent with 
the addition of three copies of the HP domain being attached at this point, 
although the resolution of these domains is too low to be able to 
unambiguously show the organisation of the HP domain or the nature of its 
exact attachment to the IGPD core.  
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Figure 5.23. - HisB HP trimer organisation. HisB reconstruction showing 
peripheral HP domain as a trimer on each corner of IGPD core rather than 
expected dimer. Insert shows zoom of trimer region. Atomic model 
adapted from PDB 2FPU (Rangarajan et al., 2006). 
 
As the final reconstruction had octahedral symmetry applied, the observed HP 
trimer may have been a symmetry artefact. In an attempt to improve the 
reconstruction of the HP domains, and to verify the proposed HP trimer, 
localised refinement, using protocols developed by Juha Huiskennen (Ilca et al., 
2015), was trialled. Sub-particles consisting of only the HP domains were 
extracted from the final particle stack giving ~126,000 sub-particles. 3D 
classification into 6 classes with no alignments was then carried out. This 
classification led to several classes showing features consistent in size and shape 
with a dimer of HP domain as well as one class showing a trimer and one other 
appearing to show a dimer with extra density alongside, potentially 
representing a lone monomer (Figure 5.24). This is perhaps not surprising as 
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crystal structures have shown the molecule to form a dimer. However, as three 
copies of this protein must be present due to its location on the three-fold vertex 
of the IGPD core, there will be a symmetry mismatch between the HP domain 
and the overall complex.  
 
 
Figure 5.24 - Localised classification of HP trimer subparticles. Results of 
subparticle classification into six classes with C1 symmetry showing 
reduction of the trimeric shape from the starting model (grey) with 
percentage of particles in each class shown above. 
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It is possible that at any given time, two copies of the HP domain exist as a 
more rigid dimer, with the third copy as a flexible monomer, which could be 
why it is not observed in the EM density. It is unclear why an enzyme that 
forms a native dimer would be fused such that it lies on a three-fold axis of the 
larger complex. The sub-particle extraction was also trialled using signal 
subtraction to remove density corresponding to the IGPD core particle prior to 
extraction of the HP sub-particle. However, in this case the HP domain showed 
poor density following 3D classification, potentially due to the smaller density 
left following the core subtraction, and no useful information was obtained. 
 
5.3 IAPA Binding Study 
It is interesting to note that this HisB fusion complex is formed of steps 6 and 8 
in the histidine biosynthesis pathway, rather than 6/7 or 7/8. If this complex 
existed in isolation, this would require the product of the 6th step (catalysed by 
IGPD) to diffuse away from the complex, be processed by the 7th element and 
then return to the HisB complex again, a seemingly inefficient process (Figure 
5.1). As such the binding of the 7th protein, IAPA, to this complex was then 
investigated as formation of a supercomplex would allow more efficient 
transfer of substrate between the elements of the pathway.  
 
IAPA was cloned, expressed and purified by Dr. Clair Phillips. Crosslinking 
studies were performed, but no binding was observed upon addition of IAPA 
to the HisB sample. In addition, negative stain classes of HisB showed no extra 
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density upon incubation with IAPA. This shows that simple addition of the 
components together is not sufficient to initiate formation of any larger species 
and suggests that either a more complex formation pathway is required or that 
no larger complex is formed. 
 
5.4 Conclusions 
While traditionally structure-guided inhibitor design has been underpinned 
through X-ray studies, the increasing power of EM has allowed it to become a 
viable method for ligand identification. Resolutions sufficient to visualise side 
chain density have become viable for many systems and the work in this section 
has shown inhibitor density at ~2.6 Å resolution. The global 3.1 Å resolution  
allowed an atomic model to be built in de novo fashion from only EM density, 
illustrating the potential of EM for identifying inhibitor binding sites and 
informing inhibitor design. At the start of this study there were few examples of 
EM being used to directly visualise binding of small molecule inhibitors to a 
protein. This work has shown one of the first examples of EM being used to 
build a de novo atomic model using only EM information and directly observe a 
bound inhibitor within the map. This work represents the smallest inhibitor 
(205 Da) to be visualised directly by EM to date and it is also the first use of 
difference maps to identify a bound inhibitor within an EM reconstruction.  
 
Despite the resolution of the EM reconstruction not allowing unambiguous 
assignment of the inhibitor pose and position, this could be established using in 
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silico docking procedures with the final result in good agreement with a known 
crystal structure used for validation purposes. It is, however, interesting to note 
that the inhibitor position observed in the crystal structure does not precisely 
match the EM reconstruction. This may be due to simply resolution, subtle 
differences between the crystalline and frozen hydrated state, or an artefact of 
radiation damage in the EM structure. 
 
Furthermore, this work has also explored the structure of the HisB protein, 
which has proven intractable via crystallographic techniques and has shown the 
trimeric arrangement of the HP domain for the first time.  
 
However, it is worth noting that the IGPD system used for this study is perhaps 
an unrepresentative test case for the utility of EM in drug discovery efforts. The 
complex forms an extremely stable, highly symmetric structure, reducing the 
amount of data required and increasing the likelihood of obtaining high 
resolution. In addition the inhibitor used was already highly potent, avoiding 
potential issues with binding site occupancy which may prove challenging in 
many cases, particularly in early stages of compound development or 
fragment-based methods. Thus, while this study has shown promise, it is likely 
that for many other targets of interest, for example the V-ATPase, EM studies 
will prove significantly more difficult. It is worth noting that for membrane 
proteins, a key target for drug discovery efforts, there have been no <3 Å EM 
structures to date, illustrating the challenges still ahead in the routine use of EM 
for drug discovery. 
  
187 
6. Discussion 
The initial aim of this PhD was to investigate the use of EM as a complementary 
technique to aid the drug discovery process. At the onset of the project the 
resolutions typically obtainable via EM for non symmetric objects (~1 nm 
resolution at best) meant a tagging approach was envisaged. By adding a large 
bulky tag to the inhibitor of interest it was hoped it could be easily localised via 
EM to provide approximate information on the binding location, which could 
be expanded further through other approaches. For example, identifying the 
specific subunit within a larger complex by tagging in EM, which could then be 
analysed through co-crystallization experiments. The goal was to then 
functionalise the tag through tag transfer chemistry (Fujishima et al., 2012; 
Tamura et al., 2012), so that the modified area of the protein could then be 
easily identified via mass spectrometry analysis, giving both global and local 
sequence location of the binding site. This tagging approach was trialled using 
PA1b, a potent toxin inhibitor of the V-ATPase. By labelling the toxin with a 
bulky horseradish peroxidase tag the binding site was identified at the base of 
the Vo domain, binding to subunits c and e. This also allowed the identification 
of the approximate location of the elusive e subunit for the first time. 
 
However, around this time what is now sometimes referred to as the 
‘Resolution Revolution’ in EM was taking place (Kühlbrandt, 2014). It was 
apparent that while this tagging approach could potentially be a powerful tool, 
with improving resolutions came the opportunity to study inhibitor binding via 
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EM in a more direct fashion. At that point EM had only given modest 
reconstructions of the V-ATPase at 11 and 16 Å from yeast and M. sexta, 
respectively. As such cryo-EM studies were carried out on the V-ATPase in 
order to improve this resolution and determine if EM could be used to inform 
the design of new V-ATPase inhibitors. As a result, the first sub nm structure of 
the V-ATPase was obtained from M. sexta, showing a different catalytic state to 
that previously observed in yeast. While this structure was superseded by yeast 
structures in three catalytic states at higher resolution, it did provide insight 
into the mechanism of the V-ATPase. This included analysis of a previously 
ignored electrostatic bearing region. It is likely that the resolution of the M. sexta 
reconstruction was limited largely due to particle number, with only ~12k 
V-ATPase particles collected as opposed to the ~250k initially picked particles 
in the yeast dataset. However, even with more data available the yeast system 
still is limited to ~7 Å resolution. Thus other causes for the limited resolution 
were investigated.  
 
As part of this work flexibility within the V-ATPase was studied. This showed 
flexing of the V1 and Vo domains of ~7° in class averages, consistent with MD 
simulations and crystallographic studies. A larger flex of ~30° was also 
observed which was affected by the addition of ATP and could represent a 
degraded or dissociating complex. This flexibility exists in addition to the 
multiple conformational states which exist in the sample as a result of catalytic 
cycling. The resolution degradation due to the flexibility along the molecule 
was partially mitigated in the cryo-EM data set through the use of tight local 
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masks and fine angular sampling, improving the V1 domain by ~2 Å, with local 
resolution extending to ~6 Å. However this had no effect on the smaller Vo 
domain. 
 
In addition to studying the full V-ATPase complex, cryo-EM studies were 
carried out on the isolated V1 domain in order to probe the mechanism by 
which regulation and ATP silencing occurs following dissociation of the 
complex. As such structures of V1 from intact complex, naturally dissociated 
complex and degraded complex were solved by cryo-EM and compared. 
However, no obvious structural changes which could cause ATP silencing were 
identified, although some variability in the AB domains in the open site was 
observed. Subunit H had been proposed to play a role in ATP silencing through 
a structural rearrangement allowing it to contact the central rotor axle (Oot et 
al., 2016), but this was not observed in our EM reconstructions of either V1 
domain. This maybe due to differences in higher and lower eukaryotes (M. sexta 
vs yeast), crystallization artefacts or limited resolution but suggest that 
regulation is not through a simple rearrangement of subunit H. Surprisingly 
there appeared to be little difference between the supposedly natural and 
relevant dissociated sample and the V1 which was obtained as a result of 
degradation of the full complex. This suggests that potentially studies carried 
out on isolated V1 do not fully reflect the natural process of regulation. 
 
While the moderate resolution obtained for the V-ATPase does allow for fitting 
of known atomic coordinates into the map, potentially allowing binding sites at 
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subunit interfaces to be identified, it was clear that it would be insufficient for 
traditional structure based drug design approaches. As such a new model 
system was identified which was hoped would be more amenable to achieving 
high resolution reconstructions, illustrating the potential for EM as a tool for 
drug discovery. AtIGPD2 was chosen as a model system as it possessed 
octahedral symmetry, thus reducing the amount of data needed drastically 
compared to an asymmetric system. Several potent (~20 nM) inhibitors were 
also available, mitigating any potential issues arising from partial occupancy 
within the complex. In addition it was known to be a very stable complex with 
several high resolution crystal structures available to aid in validation of the EM 
structure. This allowed a ~3.1 Å reconstruction of the complex to be obtained, 
allowing de novo building of an atomic model into the EM reconstruction. A 
difference map was then used to identify the inhibitor binding site, with clear 
density corresponding to the inhibitor visible. Validation with existing crystal 
structures showed extremely good agreement, with minor differences likely a 
product of differing resolutions and the radiation damage present in the EM 
reconstruction. In addition the structure of the related HisB complex from E. coli 
was solved by cryo-EM to ~7 Å showing the trimeric arrangement of the 
catalytic histininol phosphatase domains for the first time. 
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6.1 Concluding remarks and future perspectives 
This thesis aimed to explore a simple question; could cryo-EM play a useful role 
in the drug discovery process? In short, the answer is yes. This work has shown 
that cryo-EM can provide valuable information at all resolution ranges; from 
low resolution binding site identification, to direct visualisation of a bound 
small molecule inhibitor.  
 
However, there are important caveats which must be considered. Firstly, while 
always expanding, there is a limited range of proteins where high resolution 
EM studies are viable. Indeed at the present time it seems unlikely that 
structures of large, dynamic systems like the V-ATPase will be obtained at 
resolutions where direct visualisation of inhibitor binding will be viable. The 
model system used in this work (IGPD) represents the best case scenario, 
combining high symmetry with stability and potent inhibitors. This is unlikely 
to be the case for many interesting molecular targets. Secondly, and perhaps 
more importantly, how valid is the information that we obtain from these 
reconstructions? As the information contained within the earliest moments of 
an exposure is currently unusable due to apparent beam induced movement, 
EM is limited to producing reconstructions made from protein which has 
already undergone a significant radiation dose. Nevertheless, when comparing 
atomic models obtained from EM reconstructions with their X-ray counterparts 
little difference is observed, suggesting that while damage may be occurring, 
the answer obtained is little changed at the resolution ranges observed. Finally 
a practical concern, throughput. While crystallographers can routinely collect 
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diffraction data and solve preliminary structures in a matter of minutes, in EM, 
data collection takes hours or days and the subsequent data processing weeks 
or months after this. Thus the concept of screening several different analogues 
of a compound to explore subtle changes in binding becomes far less viable. 
 
The good news is that all of these challenges are being addressed by the field. 
Work is on-going from improvements in imaging conditions and specimen 
supports, to retain as much of the early undamaged information as possible, to 
novel grid preparation techniques and automated data collection/processing 
pipelines offering the possibility of rapid collection of multiple samples. EM can 
also provide valuable structural information on proteins which are intractable 
by other techniques like crystallography or NMR across a wide resolution 
range. The tagging approaches originally planned may prove to be another 
powerful tool for studying inhibitor binding via EM. It is also important to 
remember the wealth of complimentary information EM can provide away 
from simple single static structures, from identifying conformational states in 
dynamic proteins to visualising proteins in more natural environments.  
 
In conclusion, while challenges remain, the field of EM is constantly evolving 
and improving. Soon the most important question left to answer may be “What 
do we do now we’ve solved all of the structures?” 
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